Next Article in Journal
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation
Next Article in Special Issue
Pd-Catalyzed Direct Diarylation of Sodium Hypophosphite Enables the Synthesis of Diarylphosphonates
Previous Article in Journal
Standardized Chromatographic and Computational Approaches for Lipophilicity Analysis of Five Gliflozin Antidiabetic Drugs in Relation to Their Biological Activity
Previous Article in Special Issue
Synthesis of Aminobisphosphinates through a Cascade Reaction between Hypophosphorous Acid and Bis(trimethylsilyl)imidates Mediated by ZnI2
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores

by
Jeanne M. Favret
and
Sergei V. Dzyuba
*
Department of Chemistry and Biochemistry, Texas Christian University, Fort Worth, TX 76129, USA
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(1), 116; https://doi.org/10.3390/molecules30010116
Submission received: 2 December 2024 / Revised: 28 December 2024 / Accepted: 29 December 2024 / Published: 31 December 2024
(This article belongs to the Special Issue Recent Progress in Organophosphorus Chemistry)

Abstract

:
Phosphorus-containing fluorophores provide a versatile framework for tailoring photophysical properties, enabling the design of advanced fluorogenic materials for various applications. Boron dipyrromethene (BODIPY) and squaraine dyes are of interest due to their multifaceted modularity and synthetic accessibility. Incorporating phosphorus-based functional groups into BODIPY or squaraine scaffolds has been achieved through a plethora of synthetic methods, including post-dye assembly functionalization. These modifications often influence key spectroscopic properties and molecular functionality by expanding their utility in bioimaging, sensing, photosensitization, and theranostic applications. By leveraging the tunable nature of phosphorus-containing moieties, these dyes hold immense promise for addressing current challenges in spectroscopy, imaging, and material designs while unlocking new opportunities for advanced functional systems in chemistry, biology, and medicine.

1. Introduction

Organophosphorus compounds are versatile molecules with diverse applications spanning modern sciences, technology, medicine, and everyday life [1,2,3,4,5,6,7,8,9,10,11,12]. Many phosphorus-containing functional groups, along with developed chemistries for their installations and functionalization, provide endless possibilities for phosphorus incorporation into various useful scaffolds and systems. Phosphorus-containing fluorophores have been of interest due to their diverse photophysical properties [13,14,15,16,17].
Among the numerous classes of fluorescent molecules, squaraine and BODIPY dyes (Figure 1) are arguably the most versatile scaffolds due to the tunability of their photophysical properties by introducing structurally and functionally diverse moieties [18,19,20,21,22,23,24,25,26,27]. Interestingly, both dyes were first synthesized by Alfred Treibs and coworkers in 1965 (squaraine) [28] and 1968 (BODIPY) [29].
BODIPY and squaraine dyes possess other notable and important similarities, including relatively straightforward and modular syntheses, as well as possibilities for post-dye assembly modifications [18,19,20,21,22,23,24,25,26,27]. BODIPY dyes provide multiple points for functionalization employing a range of synthetic organic reactions, whereas post-functionalization strategies of squaraine dyes could be relatively restricted due to the electrophilicity of the four-membered central ring. Nonetheless, the incorporation of this versatile fluorogenic scaffold still provides a wide range of opportunities for generating systems of wide utility.
This review summarizes accounts on BODIPY and squaraine dyes that feature various phosphorus-containing moieties. Although the scope of P-containing squaraines is comparably narrower than that of the P-containing BODIPY dyes, the research on squaraine analogues could rapidly expand owing to the straightforward introduction of various functionalities, thereby generating significant contributions within the fields of spectroscopy, imaging, and sensing.

2. General Synthetic Routes to BODIPY and Squaraine Dyes

Synthesis of symmetric BODIPY dyes generally relies on an acid-catalyzed condensation reaction between carbonyl-containing compounds (primarily aldehydes and acid chlorides) and various pyrroles, followed by the oxidation that generates a conjugated system and subsequent installation of BF2-moeity under basic conditions (Scheme 1, left) [18,19,20,21,22]. Non-symmetric BODIPYs are synthesized in a similar manner (Scheme 1, right). Typically, these syntheses of BODIPYs could be accomplished in one pot, either using solution and solid (mechanochemical) approaches, followed by chromatographic purification.
Synthesis of symmetric squaraine dyes is typically accomplished via a one-step condensation of various, typically strong, nucleophiles with squaric acid (Scheme 2, left) [23,24,25,26,27]. Non-symmetric squaraines are synthesized via multistep processes (Scheme 2, right). In general, toluene/n-butanol mixtures are used as solvents (Scheme 2), although other solvents and solvent-free alternatives have been reported. Desired squaraines are isolated either by precipitation, followed by extensive washings with solvents or column chromatography.

3. BODIPY and Squaraine Dyes with Phosphorus Bound to Carbon

3.1. Phosphonate-Containing Dyes

Neutral (or zwitterionic) dyes, such as BODIPYs and squaraines, usually possess limited solubility in aqueous milieu, which hinders their use in many biological applications. To overcome these limitations, a number of water-soluble versions of such dyes have been reported [30,31,32,33,34,35].
Incorporation of phosphonate groups onto the dyes’ scaffolds resulted in water-soluble BODIPY dyes 14 [36] (Scheme 3) as well as 5 and 6 [37] (Scheme 4), with the phosphonate groups being incorporated into various positions of the BODIPY scaffold. Not surprisingly, λabsmaxemmax for dyes 3 (500 nm/509 nm) and 4 (638 nm/654 nm) appeared to be very similar to typical BODIPY and styryl-BODIPY dye due to the remote, non-conjugated to BODIPY-scaffold nature of the phosphonate group. Due to the high polarity of the phosphonate group, drawbacks were encountered that potentially limit the utilization of these types of dyes. Specifically, the high polarity of the phosphonate group, while enhancing water solubility, often compromises dye stability under physiological or acidic conditions and limits membrane permeability, posing significant challenges for both synthesis and biological applications. Dye 5 was found to be unstable, resulting in a yield that was too low to quantify following HPLC purification [37]. Dye 6 appeared to be more stable, yet reverse-phase chromatography had to be used to obtain the pure dye.
Most photophysical properties, such as λabs, λem, fluorescence lifetime (τ), and fluorescence quantum yield (Φf) of 3 and 4 [36] in H2O, were found to be virtually identical to those found in MeOH or EtOH (solvents in which BODIPY dyes are typically very soluble), suggesting the aggregation state of these dyes was similar to that found in polar organic solvents.
On the other hand, dye 6 (Scheme 4) exhibited a superior quantum yield (i.e., Φf = 0.76) compared to other prepared water-soluble BODIPYs (Φf was in the 0.36–0.59 range) [37]. This was attributed to a restricted rotation of the tertiary amide moiety, which was theorized to have reduced the probability of non-radiative pathways. Despite the dye’s advantageous level of brightness, it was mentioned that the phosphonic acid group could be an impediment to cell permeability of this dye, potentially limiting its used as a probe in imaging applications.
The varying reactivity of the methyl groups at different positions on the BODIPY scaffold enabled selective bromination at the 3- and 5-positions, followed by reaction with triethyl phosphite to yield mono- and di-phosphonate-containing BODIPY dyes 7 and 8 (Scheme 5) [38].
Silver-mediated one-step phosphonate-group installation onto the BODIPY scaffold provided entry to mono- and di-substituted (i.e., 9 and 10, respectively) dyes by simply adjusting the amounts of dialkyl phosphite (Scheme 6) [39]. Furthermore, 9 was converted into a water-soluble 11 (Scheme 6), and the high solubility of 11 in aqueous media (water, pH 6 and pH 8) was supported by the fact that the photophysical properties of 11 in water were closely related to those observed in DMSO.
Unlike the aforementioned examples, which relied on modification of the BODIPY scaffolds, an alternative, more modular strategy utilized the incorporation of phosphonate group onto terephthalaldehyde, which was subsequently used to make BODIPY dye 12 (Scheme 7) [40]. λabsmaxemmax 12 (488–492 nm/511–518 nm) in several solvents (e.g., toluene, CH3CN, EtOH, and CH2Cl2) indicated that the phosphonate group did not have an appreciable impact on its photophysical properties.
Several phosphonate-containing BODIPY dyes, i.e., 1316, were investigated computationally using DFT and DFT-TD calculations (Figure 2) [41]. Comparable photophysical properties to experimental data were obtained using HSEH1PBE functional in combination with 6-31+G** basis set. However, the specific effects of the phosphonate groups might be hard to decouple from other functional groups.
Examples of phosphonate-containing squaraines have been limited. Synthesis of 17 was accomplished using standard protocols for indolinium types of squaraine dyes (Scheme 8) [42]. Dye 17 was found to be soluble in aqueous media within the 4.0–9.3 pH range and yet insoluble in the media with pH 1.0 (0.1 M HCl). Both absorption and emission maxima appeared to be pH-independent (λabsmaxemmax: 637/647 nm at pH 9.3 (0.1 M Na2CO3/0.1 M NaHCO3 buffer), 635/644 nm at pH 7.3 (PBS buffer), and 634/643 nm at pH 4.0 (1 M NaH2PO4)). Fluorescence quantum yield for 17 was found to be relatively low (Φf = 0.04) over the same 4.0–9.3 pH range. However, when 17 was conjugated to sheep γ globulin (S-IgG) in a 1:1 ratio (conversion of 17 to NHS-17 ester was accomplished using standard coupling conditions: TSTU (O-(N-succinimidyl)-1,1,3,3-teramethyluronium tetrafluoroborate), iPr2NEt, DMF/H2O, to give mono/di-NHS ester in ca. ¼ ratio) the quantum yield of the obtained conjugate (17–S-IgG), increased almost four-fold (Φf ca. 0.16) in both pH 7.3 and 9.3 buffers. However, a gradual decrease of the quantum yield to original value of 0.04 was observed with the increase 17/S-IgG ratio (from 1:1 to 5:1), suggesting that aggregation could have been responsible for the low quantum yield of 17.

3.2. Phosphine-Containing BODIPY Dyes

Although primary phosphines are known for their high reactivity and low air stability, dyes 18 and 19 demonstrated remarkable air stability in both solution and solid states, with no oxidation taking place over a week as well as during purification using column chromatography (Scheme 9) [43]. Additionally, DFT calculations performed on 18 and 19 revealed that phosphorus contribution was prominent only in HOMO-3 (18) and HOMO-7 (19), consistent with a reduced oxidation propensity of the P-center [44].
Dye 18 was also shown to undergo several additional transformations enabled by zirconium catalyst A (Scheme 10) [45]. A catalyzed hydrophosphination and dimerization of 18 to give dyes 20 and 21, respectively [45]. λemmax for these dyes (i.e., 20 and 21) were very similar to the parent dye 18. 31P and 1H NMR study (as well as LC-MS) indicated that 21 existed as a mixture of rac and meso isomers. Thus, the potential rotor-like behavior, along with their associated applications as viscosity and temperature sensing, could be of interest. The zirconium-containing dye 22 (Figure 3), suggested to be the reactive catalytic species, was synthesized by simply reacting equimolar amounts of 18 with A (Scheme 10) in toluene for 10 min, following low-temperature crystallization. However, no photophysical properties for 22 were reported.
The ability of 18 to form air-stable fluorescent complexes with other metals was also demonstrated (Figure 3) [46]. Molybdenum- and wolframium-containing mono- and di-BODIPY complexes 23 and 24 were prepared in a facile manner, using photochemical and thermal approaches, respectively, and then isolated using column chromatography. The photophysical properties of these dyes were nearly identical to 18, indicating the lack of interaction between metal–phosphine moieties and BODIPY core.
Tertiary phosphine-containing BODIPY dyes 2528 were investigated for their ability to form various complexes group 11 metals, i.e., Cu, Ag, and Au, also known as coinage metals (Scheme 11) [47]. Monomeric and dimeric metal complexes were obtained by simply controlling the stoichiometries. Notably, isolation and purification of these complexes was performed either by recrystallization or column chromatography. In general, it was shown that the incorporation of the metal center had a negligible effect on the λabsmaxemmax and quantum yields of these dyes, yet the extinction coefficients for dimeric complexes were nearly doubled compared to the parent dyes.
Tethering phosphine moieties to the BODIPY scaffold [48] enabled the investigation of how metal complexation could be used to control fluorescence emission (Scheme 12). Phosphino-amine 29 and phosphino-thioethers 30 and 31 both demonstrated complimentary OFF-ON fluorescence responses upon specific complexation with Pt(II), with these responses being further modulated by chloride ions through induced coordination changes. Specifically, emission (fluorescence quantum yield, Φf) of 29 was relatively low (Φf = 0.07), and it was further decreased upon Pt-coordination, i.e., 32f = 0.03); yet removal of Cl from the coordination sphere of Pt resulted in a relatively emissive 35f = 0.32). The opposite trend was observed for 30 and 31: the emission gradually decreased from 30/31f 0.83/0.91) to 33/34f 0.64/0.76) to 36/37f 0.15/0.16) [48].
In an effort to develop novel metal-containing therapeutic agents, 38 scaffold was prepared [49], followed by incorporation of Ru, Os, and Au to give dyes 38-Ru, 38-Os, and 38-Au, respectively (Scheme 13). As expected, due to the remote position of the phosphine and metal moieties from the BODIPY core, both λabsmax and λemmax remained relatively unchanged upon metal complexation. Small changes in the quantum yields were attributed to possible photoinduced electron transfer (PET) processes associated with the presence of Ru(II) and Os(II) centers. Confocal microscopy studies revealed that these dyes preferentially accumulate in the cell membrane. Importantly, all three dyes exhibited cytotoxicity toward ovarian cancer cell lines (e.g., A2780S and A2780cisR), albeit the cytotoxicity was inferior to that exhibited by cisplatin.
To aid in the visualization of Ru-containing drug candidates, several BODIPY dyes were prepared (Scheme 14) and evaluated for their toxicity toward cancer lines as well as their ability to suppress cancerous tumor growth [50]. Specifically, dyes 25 and 38 underwent Staudinger reaction with 2-pyridinecarbonyl azide to give dyes 39 and 40, which were subsequently metalated, to produce air-stable 39-Ru and 40-Ru, respectively (Scheme 14) [50]. Although λabsmaxemmax did not change appreciably as the PPh2 functionality was gradually elaborated into iminophosphorane and Ru-iminophosphorane, the quantum yield decreased appreciably upon incorporation of the Ru center. The quenching effect is especially pronounced for 39-Ru, where Ru is located nearer to the BODIPY core (i.e., direct interaction between the metal center and the BODIPY), which was attributed to PET and/or increased contribution of the triplet states. Confocal microscopy revealed that, similarly, these dyes accumulated in the nucleus, mitochondria, and cytoplasm. Although BODIPY allowed for fluorescent tagging of the Ru-complexes, BODIPY moiety had a negative impact on cytotoxicity (e.g., IC50 values for 39-Ru and 40-Ru were over an order of magnitude higher as compared to 41 in several cell lines, including triple-negative breast cancer/MDA-MB-231, non-tumorigenic breast/MCF10a, and lung fibroblasts/IMR-90).
Leveraging multiple functionalization points of the BODIPY core, more advanced theranostic BODIPY platforms were synthesized, featuring tunable selectivity, solubility, cytotoxicity, and optical imaging capabilities (Scheme 15) [51]. The photophysical properties of 4249absmaxemmax were in the range of 475–516 nm/533–570 nm) did not show significant correlations as a function of structural variation, and they were acceptable for in vitro investigations. Confocal imaging revealed that these dyes mostly accumulated in the cytoplasm and/or membrane. Notably, the presence of two Au centers, i.e., 43, 44, and 49, did not provide increased Au uptake. Although Au uptake was found to correlate with cytotoxicity, the cytotoxicity of these dyes toward human breast, murine mammary, and human melanoma cancer cell lines was relatively low, with IC50 values being in the 20–100 μM range, indicating limited cytotoxic potential [51].
Due to the potential of rhenium complexes being used as theranostic agents [52], primary phosphane-containing BODIPY 18 was converted into triphosphine ligand 50, facilitating the synthesis of 51 (Scheme 16) [43,53]. From the synthetic standpoint, it is notable that simply switching the solvent (from mesitylene to toluene) allowed to obtain isomeric dyes 52-cis,mer and 52-cis,fac (along with 51), which were separated using column chromatography [53]. A related dye 53 was obtained under similar conditions (Scheme 16) [53]. Photophysical properties of all dyes, i.e., 5153, were nearly identical (λabsmaxemmax: 512–513 nm/526–528 nm; Φf: 0.18–0.28), and suitable for bioimaging applications. Specifically, 51 and 53 were shown to be viable imaging agents for prostate carcinoma (PC-3) cells. However, it appeared that although 51 possessed no cytotoxicity toward PC-3 cells, 53 was found to cause some morphological changes in PC-3 cells and exhibited MI50 values (concentration that reduces mitochondrial metabolism to 50%) of 45 ± 5 μM.
In light of utilizing 99mTc-containing ligands in single-photon emission computed tomography (SPECT), dye 54 was prepared (Scheme 17) [53]. Radio-HPLC, under in vitro simulated conditions (1 mM cystine, 10 mM [PO4]3–, pH 7.2, 37 °C), revealed that 54 remained stable up to 18 h. Thus, 54 was proven to be a viable bimodal (fluorescence imaging/BODIPY and Tc-metal/SPECT) biological probe.
A structurally similar amino-diphosphine BODIPY 55 was used for the synthesis of Rh-containing 56 (Scheme 18) to explore the potential of the BODIPY scaffold in controlling catalytic activity [54]. Notably, the fluorescence quantum yield of 56f = 0.07) was higher than that of 55f = 0.04), although both exhibited low quantum yields in absolute terms. This was attributed to the flexibility of the nitrogen substituents, which likely facilitated non-radiative decay and limited fluorescence efficiency. Upon complexation with Rh, the reduced flexibility of the side arms in 56 appeared to mitigate that effect. Importantly, 56 demonstrated efficient catalytic activity in the hydroboration of alkenes (e.g., styrene, 1-hexene, (+)-limonene, and β-pinene), albeit its performance was inferior in hydrogenation, hydrosilylation, and hydroacylation reactions [54].
Dye 57, where P of the phosphine group is directly attached to the BODIPY core, was investigated along with other dyes 58a–d that varied by the heteroatom (i.e., N, O, and S) in the meso-position of the BODIPY core (Figure 4) [55].
Compared to the parent 58a, λabsmax of 57 was red-shifted compared, while dyes with other heteroatoms, i.e., 58b–d, exhibited a pronounced blue shift. These spectral differences correlated with the electron-donating or electron-withdrawing nature of the substituents in the meso-position of the BODIPY core, as evidenced by a strong correlation with the Hammett σp+ parameter (Figure 4). These trends were further supported by cyclic voltammetry measurements and quantum mechanical calculations [55].
In sharp contrast to 58a–d, dye 57 appeared to be non-fluorescent, evident by a drastic decrease of the quantum yield (i.e., ca. 300–900-fold decrease compared to 58a). Despite this, the reported λemmax values suggested a red shift for 57 (i.e., 559 nm vs. 508 nm), consistent with the electronic effects of meso-position substituents on the BODIPY core. The non-emissive nature of 57 was attributed to the internal rotation of phenyl groups, which induced non-radiative deactivation mechanisms [55].
It was further proposed that the involvement of the non-bonding electrons of phosphorus in PET processes in the excited state could account for the non-emissive nature of dye 57 and related dyes 59 and 60 (Scheme 19) [56]. Electronic communication between phosphorus and the BODIPY core was supported by 31P NMR, which showed a triplet associated with a long-range P–F coupling (e.g., 59 4JP–F = 45 Hz and 60 4JP–F = 52 Hz). Notably, this coupling decreased or almost disappeared upon metal complexation with gold (59-Au 4JP–F = 15 Hz and 60-Au 4JP–F < 2 Hz), and the corresponding dyes exhibited pronounced enhancement of the fluorescence emission. Interestingly, the nature of the metal appeared to strongly contribute to emission of 59-metal and 60-metal complexes. For instance, based on the quantum yields, 60-Auf = 0.09) and 60-Agf = 0.07) dyes were more emissive than 60-Cuf = 0.02), while dimeric 60-Pd-60f < 0.001) was non-emissive. Consistent with these findings, the phosphine oxide derivative of 59, i.e., dye 61, where the electron pair on the phosphorus atom was removed from the conjugation with BODIPY, was also fluorescent [56].
Thus, the oxidation of phosphines to phosphine oxides (e.g., 59 to 61, Scheme 19) fundamentally represents a viable strategy for designing oxidation-sensitive OFF-ON probes (Scheme 20 and Scheme 21) [57,58]. Incorporating the phosphine group in the 3-position on the BODIPY core (i.e., 62, Scheme 20) [57] or meso-position (i.e., 57 or 65, Scheme 21) [58] provided OFF-ON probes capable of detecting ClO species (e.g., NaOCl and HOCl) in both in vitro and in vivo settings via oxidation to the respective P-oxides 63, 64, and 66. Similar to 59 and 60 (Scheme 19, [56]), the coupling between P and F was observed by 31P NMR in the case of 62, which disappeared upon conversion to 63. From the synthetic perspective, it is noteworthy that the installation of dicyclohexyl phosphine functionality within the synthesis of 62 [57] was achieved without the use of Pd, unlike 60 [56], which required a Pd catalyst.
Furthermore, while 57 exhibited OFF-ON fluorescence response upon oxidation to 64 (i.e., sensing of NaOCl) [58], which is consistent with the removal of PET, its non-rotating analogue 65 (featuring methyl groups in 1- and 7-positions) did not display a fluorogenic response upon oxidation to 66. This lack of fluorogenic response was attributed to the formation of a distorted structure, which was prone to thermal deactivation processes. However, the absorption of 65 (red solution) underwent a significant red shift (ca. 50 nm) upon conversion to phosphine oxide 66 (blue solution) as a result of NaOCl-induced oxidation. This pronounced shift might suggest the potential utility of 65 as a naked eye-detection sensor [58].

3.3. Phosphine Reactions with Squaraine: En Route to Squaraine-Chemodosimeters

The electrophilicity of the four-membered ring in squaraine dyes presents not only challenges for squaraine modification, but it also provides opportunities to expand their structural diversity and applications. For instance, several sensors and chemodosimeters (i.e., chemosensors in which optical responses are induced by the formation of a covalent bond with the analytes) have been developed based on reversible nucleophilic addition of thiols to squaraines. P-containing nucleophiles, such as P(n-Bu)3 and P(NMe2)3, were shown to react with squaraine dyes, such as 67, to produce novel chemodosimeters 68 (Scheme 22) [59]. Specifically, the rapid and efficient addition of phosphines to squaraine dyes led to stable adducts that were easily isolated simply by solvent removal and subsequent recrystallization. Notably, P(p-MeO-C6H4)3 exhibited a reversible, temperature-dependent, yet less efficient, addition to 67.
The sensing behavior of 68 (L = nBu) was evaluated with a set of transition metal ions [59]. Specifically, Pd2+, Rh+, Rh2+, Ir+, Ag+, Au3+, Cu+, and Cu2+ (in low mM-range) induced rapid, albeit partial, regeneration of 67, as evidenced by the increase of λabsmax at 656 nm. Among these, Pd2+ was the most efficient and Rh+ was the least efficient in facilitating the conversion of 68 to 67. In contrast, no increase in absorption maximum was noted in the presence of Ni2+, Fe3+, Ti3+, and Ti4+.
Subsequent studies [60,61] identified that incorporation of ortho-NHAc and ortho-OH groups onto squaraine scaffold gave dyes 69 and 70 (Scheme 23), which were shown to react with P(nBu)3 to form 71 and 72 via an unusual dearomative rearrangement [60]. Interestingly, in solution, these P-adducts (e.g., 71) appeared to exist in equilibrium with the respective squaraines (e.g., 69), as judged by the concentration-dependent 1H NMR spectra. A decrease in concentration of 71 from 100 mM to 100 μM corresponded to a 0–25% increase in 69. Furthermore, the absorption spectra of 71 (ca. 5 μM range) exhibited a measurable absorption in the 685 nm range, which corresponded to the λabsmax of 69, respectively.
Importantly, chemodosimeter 71 was effective in detecting low μM-concentrations of Pt2+, Ag+, Pd2+, Hg2+, Au+, and Rh+. (A similar response was observed in the presence of H+ as well.) Notably, a straightforward modification of the squaraine scaffold (e.g., 67 to 69) significantly enhanced the chemodosimetric sensitivity from mM-detection range in the case of 68 [59] to μM-detection range in the case of 71 [61].

3.4. Phosphonium-Containing BODIPY and Squaraine Dyes

Mitochondria are subcellular organelles critical to a variety of biological functions [62,63,64,65]. Due to its negative membrane potential of mitochondria, incorporation of lipophilic cations onto dyes’ scaffolds allows for specific delivery and imaging of mitochondria. Trisubstituted phosphonium moieties, primarily triphenylphosphonium/(Ph3P+), have been incorporated onto a wide range of fluorescent dye scaffolds [66,67]. Recently, the use of BODIPY dyes for mitochondrial imaging was comprehensively reviewed [68,69]. Here, selected dyes with distinctly different structural features are highlighted, i.e., 73–91 (Figure 5) [70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88].
As expected, the incorporation of Ph3P+ moiety via non-conjugating tethers (typically via ether, amide, or triazole linkages) to the BODIPY core did not alter the photophysical properties of the BODIPY dye scaffold. However, when conjugation was introduced at the 3- and 5-positions, such as styryl-containing dyes 8284, 87, and 91 (Figure 5), the emission was shifted toward the near-IR range. Further shifts (i.e., λemmax > 700 nm) were achieved by incorporating Ph3P+ moiety onto aza-BODIPY scaffold, such as 85 and 86 (Figure 5). It is noteworthy that while most BODIPY-Ph3P+-containing probes exhibited an ON-OFF type of fluorescence responses, some probes, including 8991 (Figure 5), operated via a ratiometric emission mechanism.
Mitochondrial membrane potential of cancer cells is typically higher than that of normal cells [89]. Consequently, introducing multiple Ph3P+ groups onto the dyes’ scaffolds may enhance their electrostatic interaction and thus lead to higher localization of these dyes in cancer cells. A recent study [90] examined mitochondria imaging capabilities of nanoparticles (NPs) comprised of dimeric BODIPY dyes 92-H and 92-Et (Scheme 24). NPs, with a size of 35–38 nm, were prepared by dissolving the corresponding dyes in acetone, followed by the addition of water and overnight evaporation of acetone. Importantly, zeta-potential studies revealed the Ph3P+ moieties were positioned at the surface. Due to the twisted structure of the two BODIPY units, the emission spectra of dyes 92-H and 92-Et exhibited a significant dependence on the solvent polarity. The emission intensities and quantum yields were drastically lower in polar solvents (e.g., EtOH and CH3CN) than in polar solvents (e.g., toluene). However, although the emission intensity of 92-H-NP and 92-Et-NP in water was relatively low, especially when compared to the emission of 92-H and 92-Et in toluene, it was ca. 3–5-fold higher than the emission intensity of 92-H and 92-Et in polar organic solvents (e.g., EtOH and CH3CN). Confocal microscopy revealed that both 92 and 92-NP were localized in mitochondria, proven by co-localization of these dyes with mitochondrial red tracker (MTR) in breast cancer (MCF-7) and cervical cancer (HeLa) cell lines. Additionally, the presence of the twisted di-BODIPY structure, which was advantageous for facilitating the triplet-state formation, thus aided in the efficient generation of 1O2. As a result, these NP dyes exhibited photoinduced cytotoxicity upon exposure to green LED (λ = 530 nm) light, reducing cell viability in MCF-7, and HeLa cells decreased to ca. 20% in the presence of 0.1 μM of 92-H-NP and 92-Et-NP.
In order to aid in the development of multimodal agents, radioactive 18F-BODIPY with Ph3P+ group 93 was prepared (Scheme 25) and successfully evaluated to assess its ability to image myocardial perfusion using positron emission tomography/computed tomography [91].
Arguably, incorporation of various groups onto phosphonium moiety itself could further tune permeability, compatibility, and localization of the probe. Using 25 and 26 as the starting materials (for synthesis, see Scheme 11), dyes 94–C6H5 and 94–C6H11 were synthesized (Scheme 26) to compare the effects of the aromatic and aliphatic groups on MMP-dependent uptake [92]. Increased lipophilicity of the cyclohexyl group, along with the more localized positive charge on phosphorus relative to the phenyl groups, appeared to increase the MMP-dependent uptake of 94–C6H11 compared to 94–C6H5. Importantly, dye 95, where the methyl group was a longer alkyl group, demonstrated an even greater increase in uptake. Going further, incorporating an F-group could open possibilities for developing multimodal systems (e.g., 18F-version, similar to 93 (Scheme 25), albeit not made, should, in principle, provide a fluorescent/PET agent).
The bromine-containing scaffold 96 was recently prepared following standard BODIPY-type synthetic methods and subsequently functionalized with various phosphonium-containing moieties (Scheme 27) [93]. Since the phosphonium group was not in conjugation with the BODIPY core, λabsmaxemmax (497–498 nm/511–512 nm) remained virtually unchanged, with a similar trend observed for the quantum yields. However, by tuning the lipophilicity of the groups on the phosphonium moiety, it was possible to establish structural features important for probe localization and mitochondria membrane potential (MMP) sensitivity. Among 97100 probes, 98 displayed the largest sensitivity to the MMP, whereas 102 showed both superior biocompatibility and enhanced membrane potential compared to all other probes [93]. This highlighted the potential importance of ethylene glycol pendants for tuning the properties of BODIPY probes in mitochondrial imaging.
Relatively fewer examples of squaraine dyes that featured Ph3P+ moiety have been reported as probes for imaging mitochondria. However, the squaraine scaffold offers unique structural and functional possibilities, such as shifting λemmax toward the near-IR window and tuning water solubility. Specifically, non-symmetric squaraine 103 was prepared using conventional approaches to such scaffolds, with the Ph3P+ group incorporation achieved using standard amide coupling conditions (Scheme 28) [94]. λabsmaxemmax of ca. 645 nm/655 nm place 103 in between BODIPY and aza-BODIPY mitochondria probes (Figure 5). Although selective localization of 102 in mitochondria was confirmed by confocal imaging, the emission intensity was drastically reduced due to interaction with nucleophilic biothiols.
Rotaxane encapsulation has been demonstrated to be a viable strategy for preserving the chemical integrity of the squaraine-conjugated structure [95,96,97]. Accordingly, probe 104 was synthesized using solid-state approach (Scheme 29) [94]. As expected, 104 exhibited red-shifted absorption and emission maxima, along with an increased quantum yield, likely a result of restricted rotation of 104 in the interlocked assembly. Notably, no dethreading of 104 from the rotaxane was observed, and the probe exhibited good mitochondria localization in carcinoma HeLa and lung adenocarcinoma (A549) cells.
Subsequent studies focused on the incorporation of interlocked Ph3P+-containing squaraine onto superparamagnetic Fe3O4 nanoparticle to produce 105 for multimodal (i.e., fluorescence emission and T2-weighted magnetic resonance) (Figure 6) [98]. 105 exhibited photophysical characteristics to 104 and selectively stained live-cell mitochondria. As an MRI probe, 105 exhibited higher relaxation times compared to previously used Fe3O4-nanoparticle agents, such as Feridex and Resovist. Overall, the high water-solubility, good biocompatibility, and multimodal imaging capabilities, combined with the potential heat-generating nanoparticle core, suggested that 105 and related systems could serve as viable theranostic agents.
In light of the increased photostability of thio-containing squaraines at the single molecule imaging resolution [99], implementing the Ph3P+-containing squaraine 106 as a mitochondria probe was assessed (Scheme 30). Remarkably, 106 effectively accumulated in HeLa and U2OS cells while simultaneously tracking the mitochondria movement in dorsal root ganglion neurons.

4. Fluorescent Dyes with Phosphorus Not Bound Directly to Carbon

4.1. Phosphate-Containing Groups

4.1.1. Phosphate-Containing BODIPY: Control of Water Solubility

Several phosphorylation protocols were explored to prepare dye 107 (Scheme 31) [100]. While limited information was provided on the structural characterization of 107 and the intermediates (i.e., 108 and 109), photophysical studies on 107 revealed that its fluorescence lifetime was ca. five times higher (τ = 3.7 ns) than the lifetime of the corresponding HO-containing BODIPY dye (τ = 0.7 ns) that was used as a starting material in the synthesis of 107 (Scheme 31). This was attributed to the electron-withdrawing nature of PO3H2-group and, hence, removal of PET. Fluorescence correlation spectroscopy measurements indicated that 107 might be suitable for single-molecule studies. However, the stability of 107 was a significant limitation, as 107 decomposed upon drying.

4.1.2. Phosphate-Containing Dyes: Sensing of Organophosphorus Nerve Agents

Phosphorylation of hydroxyl-containing BODIPYs is an important factor to consider as it may alter internal rotations, potentially changing the spectroscopic properties of the dyes. In turn, these changes could open avenues for sensing applications. Specifically, fluorescence-based detection of organophosphorus nerve agents (albeit typically in the form of the nerve agent simulants, Figure 7) using modification of fluorophoric scaffolds has been an area of intense interest [101,102].
The ability of several HO-containing BODIPY dyes, i.e., 110, 112, and 113, to sense nerve agent simulants has been investigated (Scheme 32) [103,104]. The reactivity of the hydroxyl group with the organophosphorus agents was independent of its position on the BODIPY scaffold. However, the mechanisms responsible for the fluorescent responses of these chemodosimeters varied depending on the specific position of the HO group and, as such, on the position of the resulting phosphonate moiety. One such case was dye 112, which was found to be virtually non-emissive due to the free rotation of the meso-substituent around the BODIPY core [103]. Yet, phosphorylation of 112 with diethyl chlorophosphate (Scheme 32) produces dye 113, in which the size of the phosphonate group significantly restricted that internal rotation. As a result, the non-radiative decays were suppressed, which led to ca. 100-fold increase in fluorescence intensity. The internal rotation within dye 112, and lack thereof in dye 113, was further supported by the fluorescence lifetimes in media of varying viscosity. Dye 112 acted as a molecular rotor (and hence a molecular viscometer [105,106]), as evidenced by the linear correlation between the emission intensity and medium viscosity, with a slope of 0.23, consistent with rotor-like behavior [105,106].
In contrast, 113 (i.e., phosphorylated version of 112) did not exhibit a rotor-like behavior: the emission intensity as a function of the media’s viscosity provided a linear correlation with a slope of 0.026. These findings from steady-state emission measurements were further corroborated by fluorescence lifetime measurements. Notably, both 110 and 111 exhibited rotor-like behavior, with linear coefficients of 0.25 and 0.29, respectively, as a result of viscosity-dependent emission studies. It is significant that the detection of diethyl chlorophosphate vapors was also effectively achieved using paper strips impregnated with 112: emission was detected within 3–15 sec upon exposure to diethyl chlorophosphate vapors (132 ppm), with a detection limit of ca. 0.25 ppm.
Qualitatively similar results were obtained with a related probe 114 (Scheme 32) [104]. This probe exhibited a slower (540 s) response to DCP (compared to 112, e.g.), yet a very low detection limit (ca. 20 ppb) was reported. Importantly, due to pronounced color changes, the DCP binding could be easily detected by the naked eye using a handheld UV lamp.
Several oxime-containing BODIPY dyes, i.e., 116, 117, 118, and 119, were evaluated for their ability to sense nerve agent simulants (Scheme 33) [107,108,109]. Due to variations in conditions, direct comparisons of these chemodosimeters may not be feasible. However, reported detection limits for nerve agent simulants’ detection ranged from ca. 1 nM to 90 μM. Interestingly, in the case of 116, the formed adducts varied depending on the nature of the simulant (i.e., DCP vs. DCNP) [107]. For DCP, phosphorylation of the HO group of the oxime was observed. In contrast, for DCNP, phosphorylation occurred at the phenol group, accompanied by oxidation of the oxime to nitrile. Similar behavior was noted for 117 [108]. In both cases, the electron-withdrawing nature of the nitrile group inhibited the PET process, resulting in the formation of highly emissive species.
The nucleophilicity of the nitrogen atom in piperazine-substituted BODIPYs was explored in the context of DCP-sensing capability by dyes 125127 to produce the corresponding phosphorylated dyes 128130 (Scheme 34) [110]. Specifically, the internal rotation of the meso-substituent was controlled by placing methyl groups in 1- and 7-positions. Since the electron pair on the nitrogen was not in conjugation with the BODIPY core, the protonation was suggested to be a contributing factor to the spectroscopic changes in 127. Among the investigated compounds, dye 126 provided the highest sensitivity and the most pronounced colorimetric change in response to DCP.
The efficient phosphorylation of substituted salicylaldehydes also provided viable starting materials for the synthesis of meso-substituted phosphate ester containing BODIPYs 131 with restricted rotations (Scheme 35) [111]. Not surprisingly, due to the lack of conjugation between the BODIPY core and the phenyl substituent in the meso-position, the photophysical properties of these dyes appeared largely independent of the nature of the substituents on the phenyl ring (i.e., λabsmaxemmax 505 nm/520–525 nm, τ 4–6 ns, Φf 0.3–0.5). This approach provided a convenient platform for studying rotor-like behavior as well as energy and electron transfer processes in nerve agent–simulant systems.
Several examples of squaraine-based sensors for detecting phosphorus nerve agents have recently been reported. Squaraine dye 132 showed a chromophoric response in the presence of DCP (Scheme 36) [112]. To follow, 132 was synthesized using a standard approach and revealed solvatochromic behavior (i.e., λabsmax (DMF) 621 nm; λabsmax (CHCl3) 813 nm), which closely resembled pH-dependent changes observed in a related system [113].
The solvent-induced equilibrium between basic and zwitterionic forms of 132 was proposed as an explanation of its behavior. This hypothesis may be reasonable, given the acidic nature of CHCl3 and the basic nature of DMF (attributed to DMF’s affinity to complex formation with some Lewis acids). However, since different morphologies were observed by SEM, it could also be plausible that the solvent simply controlled the aggregation and/or solvation state of 132, resulting in distinct spectral changes. Upon addition of DCP to 132 in DMF, λabsmax underwent a shift from 621 nm to 807 nm, with a clear isosbestic point at ca. 670 nm. This provided a relatively straightforward chromophoric, naked-eye detection method for DCP. It was suggested that the nucleophilic nitrogen atom in dye 132 was reactive enough to interact with DCP to give 133, drawing some parallels to 125127 BODIPY-based dosimeters. It should be noted that similar changes were observed in the presence of HCl, whereas no changes took place upon addition of other simulants, such as DCNP.
The electrophilic character of the central four-membered ring in dyes 134 and 135 was exploited by tethering ethanolamine to the squaraine structure, allowing the primary alcohol group to react with the analyte (Scheme 37) [114]. Upon the addition of ethanolamine (330 eq.), the absorption maximum at ca. 600 nm decreased, while the absorption band appeared at ca. 300 nm. Limits of detection were in the 3–35 μM range, although mM amounts of simulants were required for visual detections.

4.1.3. Phosphate-Containing BODIPYs as Photocaging Agents

Photocages are light-sensitive moieties that temporarily mask the properties of functional groups, which are restorable upon photoinduced removal of the caging moiety. Phosphoesters have been widely employed as viable photocages in a variety of systems as they enable the attachment (and subsequent release) of drugs and probes [115,116]. Due to their photostability, activation across the visible spectral range, and the ability to install functionalities for specific targets, BODIPY dyes have been extensively used as photocaging systems for biological application [117,118]. The phosphate group is a relatively recent addition to the repertoire of BODIPY-based photocaging scaffolds, with only a few examples reported to date (Scheme 38). Photochemical efficiency (i.e., quantum yield multiplied by molar absorptivity) of phosphate-BODIPY photocages 136 and 137 have been shown to be comparable to other linkers, such as ester, halide, carbonate, and carbamate [119].
BODIPY moiety has been incorporated into an oligonucleotide via solid-state synthesis using phosphoramidite derivative 138, resulting in 139 (Scheme 39) [120]. Photorelease occurred upon exposure to 530 nm light, demonstrating the potential uses of this system in biologically relevant applications.

4.1.4. Alkylphosphocholine-Containing BODIPY

The alkylphosphocholine-containing drug miltefosine (Figure 8) has been widely used to treat parasitic diseases and has demonstrated activity against cancer cells, pathogenic bacteria, and fungi [121,122,123].
To better understand miltefosine’s mode of action, several BODIPY-containing imaging agents, i.e., 140 and 141, have been developed (Scheme 40) [124,125]. These dyes exhibited spectroscopic properties suitable for biological studies and showed specific labeling of the pathogenic areas. Importantly, the introduction of BODIPY moiety did not affect in vitro antiparasitic activity.
Of particular interest is the thiol-containing analogue 142 (Figure 9), which enabled the tethering of a cell-penetrating peptide to obtain 143 [126]. Additionally, 142 was utilized in the construction of a reduction-sensitive dual-fluorescent system 144 via disulfide bond formation [126].
A more advanced BODIPY motif 145 was developed (Scheme 41), which featured ethylene glycol-containing groups as an effort to avoid aggregation, improve solubility, and enhance brightness in aqueous milieu [127]. This dye effectively stained Acanthamoeba trophozite. From the synthesis standpoint, this could be a modular approach enabling access to libraries of fluorescent miltefosine analogues.

4.2. Phosphoramidate-Containing BODIPY Dyes

Phosphoramidates have been studied for their potential applications in biological systems, such as enzymatic inhibition, anticancer activity, and antiviral effects, as well as for their flame-retardant and anticorrosion properties [128,129,130]. Incorporation of phosphoramidate functionality, i.e., dye 146, on the BODIPIY scaffold was achieved via nucleophilic aromatic substitution reaction under MW-irradiation heating (Scheme 42) [131]. As expected, the length of the tether between the BODIPY and phosphoramidate functionalities did not impact λabsmaxemmax. However, the emission properties of 146 exhibited a pronounced dependence on solvent polarity: in non-polar solvents (e.g., hexane, THF, and EtOAc), Φf of 0.82–0.97 were observed, whereas in polar solvents (EtOH, CH3CN), Φf were in the range of 0.03–0.08. This, however, was attributed to the PET process, facilitated by the non-bonding electrons on the nitrogen on the tetrafluoro-substituted aromatic ring in the meso-position of the BODIPY core.
Similarly, nucleophilic aromatic substitution on cyanuric chloride was utilized to synthesize 147 (Scheme 43) [132]. Extensive experimentation was required to determine the optimum sequence of introducing substituents, including the synthesis of BODIPY moiety being performed on the cyanuric scaffold. NMR and computational studies revealed the presence of several rotational isomers. However, photophysical properties of these dyes have not yet been reported.

4.3. N–P-Containing Dyes: PODIPYs and PHODIPY

BF2 moiety is the most prevalent component of dipyrromethene scaffold, although other elements (e.g., Al, Ga, Co, Ni, Fe, Si, Sn, etc.) have also been employed [133,134]. Yet these systems typically exhibit lower stabilities to air and moisture when compared to BODIPYs. Unlike these cases, the incorporation of phosphorus (in the form of PO2 moiety) substantially increases the water solubility of the corresponding dyes (so-called PODIPY dyes), especially compared to their BF2 analogues. PODIPYs 148 and 149 were synthesized simply by substituting BF3·OEt2 with POCl3, followed by hydrolysis as the last step of scaffold assembly (Scheme 44) [135]. Compound 148 demonstrated some Hg2+-sensing capability [136]. Enabling calorimetric detection in solution as well as solid-state was demonstrated (though, regretfully, emission characteristics were not reported).
Dye 150 (Figure 10) was partially soluble in water, yet it exhibited a complex solvatochromic behavior in organic solvents [137]. However, this dye retained emission in the thin films, suggesting potential solid-state applications [137].
These promising results prompted a computational study [138] investigating the properties of a more diverse range of PODIPY dyes 151156 (Figure 11). The study utilized a hybrid protocol, which combined the M06-2X functional to calculate ground- and excited-state geometries and vibrational modes, with SOS-CIS(D) to compute transition energies and photophysical properties (e.g., absorption, emission, and adiabatic energies). This wavefunction-based method, complementary to DFT and TD-DFT, is particularly effective for systems with significant charge transfer or strong correlation effects, enabling a more accurate depiction of the electronic transitions and excited-state dynamics.
The study revealed that replacing the BF2 group with the PO2 group significantly influenced emission energy, dipole moments, and water solvation/complexation. Thus, these observations could have immediate practical implications. Specifically, incorporation of the PO2 group was shown to lead to larger Stokes shifts. PODIPYs possess substantially larger dipole moments, which leads to increased solubility of these dyes in polar solvents, including water. These findings highlight the potential of PODIPYs in biological environments where solubility and tunable photophysical properties are crucial.
Although a limited number of PODIPY dyes has ben synthesized to date, this theoretical investigation underscores the versatility of the PO2 group as a design component for fine-tuning (photo)physical properties of dipyrromethene dyes. The ability to manipulate key characteristics, such as solubility, emission energy, and charge transfer, makes PODIPYs a promising platform for further exploration in diverse applications.

4.4. Cyclotriphosphazene- and Cyclotetraphosphazene-Containing BODIPY Dyes

Cyclotriphosphazene [139,140,141] is an inorganic heterocyclic scaffold that allows for a fairly straightforward incorporation of various chromophoric and fluorophoric units to generate multi-dye systems of broad utility [142,143]. A series of isomeric BODIPY-cyclotriphosphazenes, 157160 (Scheme 45), were prepared by directly reacting the corresponding hydroxy-containing BODIPYs with hexachlorocyclotriphosphazene in the presence of Cs2CO3 as a base [144]. When compared to the monomeric BODIPYs, these multi-BODIPY scaffolds possessed a number of unique features: ca. three-fold larger extinction coefficients, thus indicating higher brightness; larger Stokes shifts, which suggesting potential application in labeling; and similar quantum yields, which is indicative of all BODIPY units in these dyes behaving independently (although some interaction between BODIPYs were noted in the case of 157 and 158, based on 1H NMR studies).
The reactivity of the phenolic group was utilized to prepare several BODIPY-bridged di-cyclotriphosphazene dye systems (Figure 12) [145]. 161-H, 161-Br, and 161-I virtually retained the photophysical characteristics as the parent BODIPY dyes (λabsmaxemmax, and τ) while exhibiting ca. two-fold higher extinction coefficients. Not surprisingly, the presence of Br and I atoms in 161-Br and 161-I resulted in systems capable of singlet oxygen generation, indicating that these compounds could be used as photosensitizers.
Heterofluorophoric systems, featuring BODIPY and pyrene units, i.e., 162 and 163, were also developed (Figure 12) to evaluate Förster resonance energy transfer (FRET) [146]. Both 162 and 163 dyes showed that a significant quenching of the pyrene’s (donor) emission was accompanied by enhanced emission of the BODIPY (acceptor) upon excitation of pyrene, thus indicating a very efficient FRET. The large Stokes shifts stemming from well-separated absorption and emission of pyrene and BODIPY units make these systems attractive for (bio)imaging applications, albeit structural modifications might be required to increase solubility in aqueous milieu, along with shifting excitation wavelength into the red region [146].
Using copper-catalyzed alkyne-azide cycloaddition (CuAAC, so-called click-chemistry), multi-BODIPY systems, such as pyrene–BODIPY and napthalimide–BODIPY dyads, were grafted onto a cyclotriphosphazene scaffold to give dyes 164172 (Figure 13) [147,148,149,150,151,152]. Additionally, incorporation of ethylene glycol moieties further enhanced the water solubility. Photophysical properties of these poly-dye systems were relatively like the individual dyes. However, in some systems, solvatochromic behavior was observed [151]. For example, 170 (Figure 13) displayed a pronounced solvatochromic effect, with λemmax varying within the 691–711 nm range, although 170 was not emissive in water, EtOH, and hexane. In contrast, 169 showed negligible solvatochromism across solvents of different polarity (i.e., water, acetone, dichloromethane, and hexane): λabsmaxemmax 497–500 nm/508–510 nm) [151].
More elaborate, three-component assemblies, such as BODIPY–cyclotriphosphazene–fullerene–C60 173 and 174 (Figure 14), were also prepared [153]. Though 173 and 174 were good systems to study energy/electron transfer processes, their photophysical and photochemical properties (i.e., 1O2 generation) properties were found to be similar or even inferior to non-fullerene-containing assemblies.
Encapsulation of 175 (Figure 15) [154] with an amphiphilic polymer (e.g., DSPE-PEG2000 or PEG 5000-PLA3000) produced water-soluble nanoparticles (NPs, with an average size of ca. 90 nm), with potential theranostic applications [155]. Specifically, photoacoustic and fluorescence imaging, along with photothermal treatment, were demonstrated. Notably, 175-NP selectively accumulated in 4T1 tumor-bearing mice, effectively suppressing tumor size upon exposure to 655 nm laser light [155].
Recently, spermine-modified cyclotriphosphazene scaffold was functionalized using styryl-containing BODIPY dyes (Scheme 46) [156]. Dyes 176 and 177 exhibited strong absorption and emission in the near-infrared region (i.e., λabsmaxemmax ca. 715 nm/815 nm), high photostability, and efficient singlet oxygen generation. However, all photophysical and photochemical properties of these dyes were similar to other cyclotriphosphazine-containing BODIPY dyes (e.g., Figure 13). Notably, however, red-light illumination of these halogenated derivatives induced selective phototoxicity, effectively targeting PC-3 cancer cells [156].
Several studies exploited cyclotetraphosphazene scaffold, a less commonly utilized analogue of cyclotriphosphazene to construct BODIPY-containing systems 178182 as ON-OFF cation sensors [157,158]. For example, 179 and 180 displayed high selectivity toward Co2+ over other transition metals (e.g., Cr3+, Fe3+, Cu2+, Fe2+, Mn2+, Cd2+, Ag+, and Hg+) as well as alkali and alkali earth cations (e.g., Li+, Na+, K+, Mg2+, Ca2+, and Ba2+). It is of interest to point that the incorporation of thiophene and thianaphthene moieties onto BODIPY produced ON-OFF sensors 181 and 182 (Figure 16) that exhibited selectivity not only toward Co2+ but also toward Cu2+, albeit with inferior sensitivity and detection limits. Interestingly, the extinction coefficients of 181 and 182 were substantially larger than those of 178180, thus indicating that the incorporation of some groups onto BODIPY–cyclotetraphosphazenes could potentially lead to the development of high brightness materials. However, further optimization of these structures might be needed to allow for practical utilization in metal-sensing applications due to relatively low (a) sensitivity levels (e.g., only ca. two-fold decrease of fluorescence intensity of 181 was observed in the presence of 500 molar excess of Co2+) and (b) detection limits (low μM range).
BODIPY-functionalized cyclotetraphosphazines 183 and 184 were additionally investigated as potential photosensitizers (Figure 16) [159]. However, increasing the number of BODIPY units from six to eight did not significantly alter the photochemical properties or singlet oxygen-generating capability, emphasizing the challenges in developing robust structure–property relationships for polyfluorophoric systems.

5. Conclusions

In this review, we attempted to summarize available data on phosphorus-containing BODIPY and squaraine dyes. To demonstrate the versatility of phosphorus-based moieties in tuning various photochemical properties, this review highlighted their roles in enhancing solubility, modulating emission energies, enabling efficient energy and electron transfer processes, and facilitating the design of multifunctional systems for applications ranging from bioimaging and sensing to theranostics and photodynamic therapy. While the incorporation of phosphorus groups does not always result in a unique set of photophysical properties, their versatility enables the creation of fluorogenic scaffolds with expanded functionality and application potential.
Despite these advantages, limitations remain. The stability of many P-containing dyes is a significant concern, as it could lead to rapid degradation and reduced photostability, consequently hindering their practical utility. Furthermore, the tendency of some P-containing dyes to aggregate in aqueous environments could compromise imaging applications due to aggregation-induced quenching, a common challenge in organic fluorophores, particularly in biological contexts [160,161].
Considering the broad diversity of P-containing functional groups, ongoing advancements in the development of novel fluorogenic materials tailored for emerging and advanced applications are highly anticipated. Advances in aggregation-induced emission luminogens provide a promising approach to overcoming fluorescence quenching issues, allowing to expand the utility of these materials in imaging and sensing applications [160,161]. Similarly, advancements in lipid droplet-localized photosensitizers offer valuable insights into targeting specific microenvironments [162,163]. By leveraging current progress, ongoing efforts can aim to refine P-containing dyes for broader and more versatile applications across bioimaging, sensing, and theranostics.

Author Contributions

Writing—original draft preparation, J.M.F. and S.V.D.; writing—review and editing, J.M.F. and S.V.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded in part by the Dean’s Research Opportunity Fund, Texas Christian University (TCU).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We acknowledge TCU for continued support of our work related to the development of fluorescent probes.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Singh, I.; Sivaramakrishna, A. Phosphorus-based polymeric flame retardant–recent advances and perspectives. ChemistrySelect 2024, 9, e202401485. [Google Scholar] [CrossRef]
  2. Pathiraja, G.; Bonner, C.D.J.; Obare, S.O. Recent advances of enzyme-free electrochemical sensors for flexible electronics in the detection of organophosphorus compounds: A review. Sensors 2023, 23, 1226. [Google Scholar] [CrossRef]
  3. Lidman Olsson, E.O.; Giarborg, P.; Dam-Johansen, K.; Wu, H. Review of phosphorus chemistry in the thermal conversion of biomass: Progress and perspectives. Energy Fuels 2023, 37, 6907–6998. [Google Scholar] [CrossRef]
  4. Asok, N.; Gaffen, J.R.; Baumgartner, T. Unique phosphorus-based avenues for the tuning of functional materials. Acc. Chem. Res. 2023, 56, 536–547. [Google Scholar] [CrossRef] [PubMed]
  5. Ung, S.P.-M.; Li, C.-J. From rocks to bioactive compounds: A journey through the global P(V) organophosphorus industry and its sustainability. RSC Sustain. 2023, 1, 11–37. [Google Scholar] [CrossRef]
  6. Kolodiazhnyi, O.I. Phosphorus compounds of natural origin: Prebiotic, stereochemistry, application. Symmetry 2021, 13, 889. [Google Scholar] [CrossRef]
  7. Xie, C.; Shaligo, A.J.; Song, X.-R.; Kwon, O. Phosphorus-based catalysis. ACS Cent. Sci. 2021, 7, 536–558. [Google Scholar] [CrossRef] [PubMed]
  8. Sgcharbin, D.; Bryszewska, M.; Mignani, S.; Shi, X.; Majoral, J.-P. Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overview. Eur. J. Med. Chem. 2020, 208, 112788. [Google Scholar] [CrossRef] [PubMed]
  9. Glueck, D.S. Metal-catalyzed P–C bond formation via P–H oxidative addition: Fundamentals and recent advances. J. Org. Chem. 2020, 85, 14276–14285. [Google Scholar] [CrossRef] [PubMed]
  10. Rodriguez, J.B.; Gallo-Rodriguez, C. The role of the phosphorus atom in drug design. ChemMedChem 2019, 14, 190–216. [Google Scholar] [CrossRef]
  11. Shameem, M.A.; Orthaber, A. Organophosphorus compounds in organic electronics. Chem. Eur. J. 2016, 22, 10718–10735. [Google Scholar] [CrossRef] [PubMed]
  12. Montchamp, J.-L. Phosphinate chemistry in the 21st century: A viable alternative to the use of phosphorus trichloride in organophosphorus synthesis. Acc. Chem. Res. 2014, 47, 77–87. [Google Scholar] [CrossRef] [PubMed]
  13. Belyaev, A.; Chou, P.-T.; Koshevoy, I.O. Cationic organophosphorus chromophores: A diamond in the rough among ionic dyes. Chem. Eur. J. 2021, 27, 537–552. [Google Scholar] [CrossRef] [PubMed]
  14. Thakur, D.; Sushmita; Meena, S.A.; Verma, A.K. Advancement in synthetic strategies of phosphorus heterocycles: Recent progress from synthesis to emerging class of optoelectronic materials. Chem. Rec. 2024, 24, e202400058. [Google Scholar] [CrossRef]
  15. Reus, C.; Baumgartner, T. Stimuli-responsive chromism in organophosphorus chemistry. Dalton Trans. 2016, 45, 1850–1855. [Google Scholar] [CrossRef] [PubMed]
  16. Matano, Y. Synthesis and structure-property relationships of phosphole-based π-systems and their applications in organic solar cells. Chem. Rec. 2015, 15, 636–650. [Google Scholar] [CrossRef]
  17. Hissler, M.; Lescop, C.; Reau, R. Coordination chemistry of phosphole ligands: From supramolecular assemblies to OLEDs. Compt. Rend. Chem. 2008, 11, 628–640. [Google Scholar] [CrossRef]
  18. Louder, A.; Burgess, K. BODIPY dyes and their derivatives: Synthesis and spectroscopic properties. Chem. Rev. 2007, 107, 4891–4931. [Google Scholar]
  19. Ulrich, G.; Ziessel, R.; Harriman, A. The chemistry of fluorescent bodipy dyes: Versatility unsurpassed. Angew. Chem. Int. Ed. 2008, 47, 1184–1201. [Google Scholar] [CrossRef]
  20. Boens, N.; Verbelen, V.; Ortiz, M.J.; Jiao, L.; Dehaen, W. Synthesis of BODIPY dyes through postfunctionalization of the boron dipyrromethene core. Coord. Chem. Rev. 2019, 399, 213024. [Google Scholar] [CrossRef]
  21. Yadav, I.S.; Misra, R. Design, synthesis and functionalization of BODIPY dyes: Application in dye-sensitized solar cells (DSSCs) and photodynamic therapy (PDT). J. Mater. Chem. C 2023, 11, 8688–8723. [Google Scholar] [CrossRef]
  22. Chen, Z.; Chen, Z. Functional supramolecular aggregates based on BODIPY and aza-BODIPY dyes: Control over the pathway complexity. Org. Chem. Front. 2023, 10, 2581–2602. [Google Scholar] [CrossRef]
  23. Sreejith, S.; Carol, P.; Chithra, P.; Ajayaghosh, A. Squaraine dyes: A mine of molecular materials. J. Mater. Chem. 2008, 18, 264–274. [Google Scholar] [CrossRef]
  24. He, J.; Jo, Y.J.; Sun, X.; Qiao, W.; Ok, J.; Kim, T.-i.; Li, Z. Squaraine dyes for photovoltaic and biomedical applications. Adv. Funct. Mater. 2021, 31, 2008201. [Google Scholar] [CrossRef]
  25. Illina, K.; MacCuaig, W.M.; Laramie, M.; Jeouty, J.N.; McNally, L.R.; Henary, M. Squaraine dyes: Molecular design for different applications and remaining challenges. Bioconjugate Chem. 2020, 31, 194–213. [Google Scholar] [CrossRef] [PubMed]
  26. Xia, G.; Wang, H. Squaraine dyes: The hierarchical synthesis and its application in optical detection. J. Photochem. Photobiol. C 2017, 31, 84–113. [Google Scholar] [CrossRef]
  27. Ta, D.D.; Dzyuba, S.V. Squaraine-based optical sensors: Designer toolbox for exploring ionic and molecular recognitions. Chemosensors 2021, 9, 302. [Google Scholar] [CrossRef]
  28. Treibs, A.; Jacob, K. Cyclotrimethine dyes derived from quadratic acid [1,2-hydroxycylobutenedione]. Angew. Chem. 1965, 77, 680–681. [Google Scholar] [CrossRef]
  29. Treibs, A.A.; Kreuzer, F.-H. Difluroboryl complexes of di- and tripyrrylmethenes. Justus Liebigs Ann. Chem. 1968, 718, 208–223. [Google Scholar] [CrossRef]
  30. Mahanta, C.S.; Ravichandiran, V.; Swain, S.P. Recent developments in the design of new water-soluble boron dipyrromethenes and their applications: An updated review. ACS Appl. Bio Mater. 2023, 6, 2995–3018. [Google Scholar] [CrossRef] [PubMed]
  31. Fan, G.; Yang, L.; Chen, Z. Water-soluble BODIPY and aza-BODIPY dyes: Synthetic progress and applications. Front. Chem. Sci. Eng. 2014, 8, 405–417. [Google Scholar] [CrossRef]
  32. Song, R.; Dong, Y.; Zhing, Z.; Zhao, Q.; Hu, Y.; Lei, M.; Lei, P.; Jiang, Z.; Qian, K.; Shi, C.; et al. Systematic structural modification of squaraine dye for near-infrared window one and two multiplexed in vivo imaging and photothermal therapy. J. Med. Chem. 2024, 67, 10275–10292. [Google Scholar] [CrossRef] [PubMed]
  33. Singh, S.; Meador, W.E.; Pramanik, A.; Ray, P.; Delcamp, J.H.; Zhao, Y. An indolizine squaraine-based water soluble NIR dye for fluorescence imaging of multidrug-resistant bacteria and antibacterial/antibiofilm activity using the photothermal effect. J. Photochem. Photobiol. B 2023, 240, 112652. [Google Scholar] [CrossRef] [PubMed]
  34. Gomes, V.S.D.; Ferreira, J.C.C.; Boto, R.E.F.; Almeida, P.; Fernandes, J.R.; Sousa, M.J.; Goncalves, M.S.T.; Reis, L.V. Squaraine dyes derived from indolenine and benzo[e]indole as potential fluorescent probes for HSA detection and antifungal agents. Photochem. Photobiol. 2022, 98, 1402–1417. [Google Scholar] [CrossRef] [PubMed]
  35. Hovor, I.V.; Kosolova, O.S.; Obukhova, O.M.; Tatarets, A.L.; Pantsenker, L.D. Comparison of water-soluble squaraine and norsquaraine as fluorescent material for biomedical applications. Funct. Mater. 2020, 27, 836–845. [Google Scholar]
  36. Bura, T.; Ziessel, R. Water-soluble phosphonate-substituted BODIPY derivatives with tunable emission channels. Org. Lett. 2011, 13, 3072–3075. [Google Scholar] [CrossRef]
  37. Romieu, A.; Massif, C.; Rihn, S.; Ulrich, G.; Ziessel, R.; Renard, R.-Y. The first comparative study of the ability of different hydrophilic groups to water-solubilise fluorescent BODIPY dyes. New J. Chem. 2013, 37, 1016–1027. [Google Scholar] [CrossRef]
  38. Ulrich, G.; Ziessel, R.; Haefele, A. A general synthetic route of 3,5-substituted boron dipyrromethenes: Applications and properties. J. Org. Chem. 2012, 77, 4298–4311. [Google Scholar] [CrossRef]
  39. Lv, F.; Li, H.; Wu, Q.; Zhang, H.; Yu, C.; Jiao, L.; Hao, E. Silver-mediated, direct phosphorylation of BODIPY dyes at the 3- or 3,5-positions with H-phosphonates. Chem. Commun. 2022, 58, 3937–3940. [Google Scholar] [CrossRef]
  40. Tasgin, D.I. The design, synthesis and spectroscopic/photophysical characterization of phosphonated-substituted BODIPY. Hacet. J. Biol. Chem. 2020, 48, 197–201. [Google Scholar] [CrossRef]
  41. Tasgin, D.I.; Sirin, P.S. A theoretical investigation: Effect of structural modifications on the molecular, electronic, and optical properties of phosphonate substituted BODIPY dyes. ChemistrySelect 2021, 6, 4677–4683. [Google Scholar] [CrossRef]
  42. Reddington, M.V. Synthesis and properties of phosphonic acid containing cyanine and squaraine dyes for use as fluorescent labels. Bioconjugate Chem. 2007, 18, 2178–2190. [Google Scholar] [CrossRef]
  43. Davies, L.H.; Stewart, B.; Harrington, R.W.; Clegg, W.; Higham, L.J. Air-stable, highly fluorescent primary phosphanes. Angew. Chem. Int. Ed. 2012, 51, 4921–4924. [Google Scholar] [CrossRef]
  44. Davies, L.H.; Stewart, B.; Higham, L.J. Air-stable, fluorescent primary phosphines. Organomet. Chem. 2014, 39, 51–71. [Google Scholar]
  45. Bange, C.A.; Mucha, N.T.; Cousins, M.E.; Gehsmann, A.C.; Singer, A.; Truax, T.; Higham, L.J.; Waterman, R. Zirconium-catalyzed alkene hydrophosphination and dehydrocoupling with an air-stable, fluorescent primary phosphine. Inorganics 2016, 4, 26. [Google Scholar] [CrossRef]
  46. Davies, L.H.; Wallis, J.F.; Harrington, R.W.; Waddell, P.G.; Higham, L.J. Air-stable fluorescent phosphine complexes of molybdenum and tungsten. J. Coord. Chem. 2016, 69, 2069–2080. [Google Scholar] [CrossRef]
  47. Davies, L.H.; Harrington, R.W.; Clegg, W.; Higham, L.J. BRBodPR2: Highly fluorescent alternatives to PPh3 and PhPCy2. Dalton Trans. 2014, 43, 13485–13499. [Google Scholar] [CrossRef] [PubMed]
  48. Lifschitz, A.M.; Shade, C.M.; Spokoyny, A.M.; Mendez-Arroyo, J.; Stern, C.L.; Sarjeant, A.A.; Mirkin, C.A. Boron-dipyrromethene-functionalized hemilabile ligands as “turn-on” fluorescent probes for coordination changes in weak-link approach complexes. Inorg. Chem. 2013, 52, 5484–5492. [Google Scholar] [CrossRef] [PubMed]
  49. Tasan, S.; Zava, O.; Bertrand, B.; Bernhard, C.; Goze, C.; Picquet, M.; Le Gendre, P.; Harvey, P.; Denat, F.; Casini, A.; et al. BODIPY–phosphane as a versatile tool for easy access to new metal-based theranostics. Dalton Trans. 2013, 42, 6102–6109. [Google Scholar] [CrossRef]
  50. Miachin, K.; Del Solar, V.; El Khoury, E.; Nayeem, N.; Khrystenko, A.; Appelt, P.; Neary, M.C.; Bucella, D.; Contel, M. Intracellular localization studies of the luminescent analogue of an anticancer ruthenium iminophosphorane with high efficacy in a triple-negative breast cancer mouse model. Inorg. Chem. 2021, 60, 19152–19164. [Google Scholar] [CrossRef] [PubMed]
  51. Pliquett, J.; Amor, S.; Ponce-Vargas, M.; Laly, M.; Racoeur, C.; Rousselin, Y.; Denat, F.; Bettaïeb, A.; Fleurat-Lessard, P.; Paul, C.; et al. Design of a multifunctionalizable BODIPY platform for the facile elaboration of a large series of gold(I)-based optical theranostics. Dalton Trans. 2018, 47, 11203–11218. [Google Scholar] [CrossRef]
  52. Qi, Q.; Wang, Q.; Li, Y.; Silva, D.S.; Ruiz, M.E.L.; Ouyang, R.; Liu, B.; Miao, Y. Recent development of rhenium-based materials in the application of diagnosis and tumor therapy. Molecules 2023, 28, 2733. [Google Scholar] [CrossRef]
  53. Davies, L.H.; Kasten, B.B.; Benny, P.D.; Arrowsmith, R.L.; Ge, H.; Pascu, S.I.; Botchway, S.W.; Clegg, W.; Harrington, R.W.; Higham, L.J. Re and 99mTc complexes of BodP3–multi modality imaging probes. Chem. Commun. 2014, 50, 15503–15505. [Google Scholar] [CrossRef] [PubMed]
  54. Thompson, B.L.; Simons, C.R.; Heiden, Z.M. Redox switchable catalysis utilizing a fluorescent dye. Chem. Commun. 2019, 55, 11430–11433. [Google Scholar] [CrossRef] [PubMed]
  55. Esnal, I.; Valois-Escamilla, I.; Gómez-Durán, C.F.A.; Urías-Benavides, A.; Berancourt-Mendiola, M.L.; López-Arbeloa, I.; Bañuelos, J.; Carcía-Moreno, I.; Costela, A.; Peña-Cabrera, E. Blue-to-orange color-tunable laser emission from tailored boron-dipyrromethene dyes. ChemPhysChem 2013, 14, 4134–4142. [Google Scholar] [CrossRef] [PubMed]
  56. Vasiuta, R.; Plenio, H. Observing initial steps in gold-catalyzed alkyne transformations by utilizing bodipy-tagged phosphine-gold complexes. Chem. Eur. J. 2016, 22, 6353–6360. [Google Scholar] [CrossRef] [PubMed]
  57. Bi, S.; Yang, T.; An, K.; Wang, S.; Han, Y. A phosphine-based fluorescent probe for fluorescent imaging of hypochlorous acid in living cells and zebrafish. New J. Chem. 2023, 47, 11912–11918. [Google Scholar] [CrossRef]
  58. Ma, C.; Hou, S.; Zhou, X.; Wang, Z.; Yoon, J. Rational design of meso-phosphino-substituted BODIPY probes for imaging hypochlorite in living cells and mice. Anal. Chem. 2021, 93, 9640–9646. [Google Scholar] [CrossRef] [PubMed]
  59. Bacher, E.P.; Lepore, A.J.; Pena-Romero, D.; Smith, B.D.; Ashfeld, B.L. Nucleophilic addition of phosphorus(III) derivatives to squaraines: Colorimetric detection of transition meta-mediated or thermal reversion. Chem. Commun. 2019, 55, 3286–3289. [Google Scholar] [CrossRef]
  60. Bacher, E.P.; Koh, K.J.; Lepore, A.J.; Oliver, A.G.; Wiest, O.; Ashfeld, B.L. A phosphine-mediated skeletal rearrangement of dianiline squaraine dyes. Org. Lett. 2021, 23, 2853–2857. [Google Scholar] [CrossRef]
  61. Twiringiyimana, R.; Ashfeld, B.L. Pseudoaromaticity-driven, transition metal detection by squaraine-derived enol phosphoniumylide chemodosimeters. Chem. Commun. 2024, 60, 5638–5641. [Google Scholar] [CrossRef] [PubMed]
  62. Mills, E.L.; Kelly, B.; O’Neill, L.A.J. Mitochondria are the powerhouses of immunity. Nat. Immunol. 2017, 18, 488–498. [Google Scholar] [CrossRef] [PubMed]
  63. Vyas, S.; Zaganjor, E.; Haigis, M.C. Mitochondria and cancer. Cell 2016, 166, 555–566. [Google Scholar] [CrossRef] [PubMed]
  64. Nunnari, J.; Suomalainen, A. Mitochondria: In sickness and in health. Cell 2012, 148, 1145–1159. [Google Scholar] [CrossRef] [PubMed]
  65. Hoye, A.T.; Davoren, J.E.; Wipf, P.; Fink, M.P.; Kagan, V.E. Targeting mitochondria. Acc. Chem. Res. 2008, 41, 87–97. [Google Scholar] [CrossRef]
  66. Xu, Z.; Xu, L. Fluorescent probes for the selective detection of chemical species inside mitochondria. Chem. Commun. 2016, 52, 1094–1119. [Google Scholar] [CrossRef]
  67. Zielonka, J.; Joseph, J.; Sikora, A.; Hardy, M.; Ouari, O.; Vasquez-Vivar, J.; Cheng, G.; Lopez, M.; Kalyanaraman, B. Mitochondria-targeted triphenylphosphonium-based compounds: Synthesis, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 2017, 117, 10043–10120. [Google Scholar] [CrossRef] [PubMed]
  68. Mai, D.K.; Badon, I.W.; Lim, J.M.; Vales, T.P.; Kim, C.; Yang, J.; Lee, J.; Kim, H.-J. Triphenylphosphonium-functionalized BODIPY derivatives for mitochondria-targeted cell imaging and fluorescence turn-on sensing with protein selectivity. Dyes Pigments 2023, 208, 110856. [Google Scholar] [CrossRef]
  69. Wang, S.; Gai, L.; Chen, Y.; Ji, X.; Lu, H.; Guo, Z. Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy. Chem. Soc. Rev. 2024, 53, 3976–4019. [Google Scholar] [CrossRef]
  70. Gao, T.; He, H.; Huang, R.; Zheng, M.; Wang, F.-F.; Hu, Y.-J.; Jiang, F.-L.; Liu, Y. BODIPY-based fluorescent probes for mitochondria-targeted cell imaging with superior brightness, low cytotoxicity and high photostability. Dyes Pigments 2017, 141, 530–535. [Google Scholar] [CrossRef]
  71. Yu, Z.; Zhou, J.; Dong, X.; Zhao, W.; Chen, Z. Visualizing nitric oxide in mitochondria and lysosomes of living cells with N-nitrosation of BODIPY-based fluorescent probes. Anal. Chim. Acta 2019, 1067, 88–97. [Google Scholar] [CrossRef] [PubMed]
  72. Cheng, G.; Fan, J.; Sun, W.; Sui, K.; Jin, X.; Wang, J.; Peng, X. A highly specific BODIPY-based probe localized in mitochondria for HClO imaging. Analyst 2013, 138, 6091–6096. [Google Scholar] [CrossRef]
  73. Yang, Z.; Kang, D.H.; Lee, H.; Shin, J.; Yan, W.; Rathore, B.; Kim, H.-R.; Kim, S.J.; Singh, H.; Liu, L.; et al. A fluorescent probe for stimulated emission depletion super-resolution imaging of vicinal-dithiol-proteins on mitochondrial membrane. Bioconjugate Chem. 2018, 29, 1446–1453. [Google Scholar] [CrossRef]
  74. Xu, C.; Qian, Y. The α, β-unsaturated pyrazolone-based fluorescent sensor with red emission and its application for real-life monitoring hypochlorite in cancer cells and zebrafish. Dyes Pigments 2019, 161, 303–312. [Google Scholar] [CrossRef]
  75. Gao, C.; Lin, L.; Sun, W.; Tan, Z.-L.; Huang, J.-R.; He, L.; Lu, Z.-L. Dihydropyridine-derived BODIPY probe for detecting exogenous and endogenous nitric oxide in mitochondria. Talanta 2018, 176, 382–388. [Google Scholar] [CrossRef] [PubMed]
  76. Sui, B.; Tang, S.; Woodward, A.W.; Kim, B.; Belfield, K.D. A BODIPY-based water-soluble fluorescent probe for mitochondria targeting. Eur. J. Org. Chem. 2016, 2016, 2851–2857. [Google Scholar] [CrossRef]
  77. Krumova, K.; Greene, L.E.; Cosa, G. Fluorogenic α-tocopherol analogue for monitoring the antioxidant status within the inner mitochondrial membrane of live cells. J. Am. Chem. Soc. 2013, 135, 17135–17143. [Google Scholar] [CrossRef]
  78. Kand, D.; Pizarro, L.; Angel, I.; Avni, A.; Friedmann-Morvinski, D.; Weinstain, R. Organelle-targeted BODIPY photocages: Visible-light-mediated subcellular photorelease. Angew. Chem. Int. Ed. 2019, 58, 4659–4663. [Google Scholar] [CrossRef] [PubMed]
  79. Zhang, X.; Xiao, Y.; Qi, J.; Qu, J.; Kim, B.; Yue, X.; Belfield, K.D. Long-wavelength, photostable, two-photon excitable BODIPY fluorophores readily modifiable for molecular probes. J. Org. Chem. 2013, 78, 9153–9160. [Google Scholar] [CrossRef] [PubMed]
  80. Wang, J.-L.; Zhang, L.; Gao, L.-X.; Chen, J.-L.; Zhou, T.; Liu, Y.; Jiang, F.-L. A bright, red-emitting water-soluble BODIPY fluorophore as an alternative to the commercial Mito Tracker Red for high-resolution mitochondrial imaging. J. Mater. Chem. B 2021, 9, 8639–8645. [Google Scholar] [CrossRef] [PubMed]
  81. Miao, J.; Huo, Y.; Yao, G.; Feng, Y.; Weng, J.; Zhao, W.; Guo, W. Heavy atom-free, mitochondria-targeted, and activatable photosensitizers for photodynamic therapy with real-time in-situ therapeutic monitoring. Angew. Chem. Int. Ed. 2022, 61, e202201815. [Google Scholar] [CrossRef] [PubMed]
  82. Song, X.; Bai, S.; He, N.; Wang, R.; Xing, Y.; Lv, C.; Yu, F. Real-time evaluation of hydrogen peroxide injuries in pulmonary fibrosis mice models with a mitochondria-targeted near-infrared fluorescent probe. ACS Sens. 2021, 6, 1228–1239. [Google Scholar] [CrossRef] [PubMed]
  83. Gao, M.; Wang, R.; Yu, F.; Chen, L. Evaluation of sulfane sulfur bioeffects via a mitochondria-targeting selenium-containing near-infrared fluorescent probe. Biomaterials 2018, 160, 1–14. [Google Scholar] [CrossRef] [PubMed]
  84. Kong, X.; Su, F.; Zhang, L.; Yaron, J.; Lee, F.; Shi, Z.; Tian, Y.; Meldrum, D.R. A highly selective mitochondria-targeting fluorescent K+ sensor. Angew. Chem. Int. Ed. 2015, 54, 12053–12057. [Google Scholar] [CrossRef]
  85. Dodani, S.C.; Leary, S.C.; Cobine, P.A.; Winge, D.R.; Chang, C.J. A targetable fluorescent sensor reveals that copper-deficient SCO1 and SCO2 patient cells prioritize mitochondrial copper homeostasis. J. Am. Chem. Soc. 2011, 133, 8606–8616. [Google Scholar] [CrossRef] [PubMed]
  86. Liu, X.-L.; Niu, L.-Y.; Chen, Y.-Z.; Zheng, M.-L.; Yang, Y.; Yang, Q.-Z. A mitochondria-targeting fluorescent probe for the selective detection of glutathione in living cells. Org. Biomol. Chem. 2017, 15, 1072–1075. [Google Scholar] [CrossRef] [PubMed]
  87. Prime, T.A.; Forkink, M.; Logan, A.; Finichiu, P.G.; McLachlan, J.; Li Pun, P.B.; Koopman, W.J.H.; Larsen, L.; Latter, M.J.; Smith, R.A.J.; et al. A ratiometric fluorescent probe for assessing mitochondrial phospholipid peroxidation within living cells. Free Radic. Biol. Med. 2012, 53, 544–553. [Google Scholar] [CrossRef]
  88. He, R.; Zhang, Y.; Madhu, S.; Gao, Q.; Lian, Q.; Raghavan, S.S.; Geng, J. BODIPY based realtime, reversible and targeted fluorescent probes for biothiol imaging in living cells. Chem. Commun. 2020, 56, 14717–14720. [Google Scholar] [CrossRef] [PubMed]
  89. Huang, M.; Myers, C.R.; Wang, Y.; You, M. Mitochondria as a novel target for cancer chemoprevention: Emergence of mitochondrial-targeting agents. Cancer Prev. Res. 2021, 14, 285–306. [Google Scholar] [CrossRef] [PubMed]
  90. Kim, C.; Mai, D.K.; Lee, J.; Jo, J.; Kim, S.; Badon, I.W.; Lim, J.M.; Kim, H.-J.; Yang, J. Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy. Nanoscale 2024, 16, 9462–9475. [Google Scholar] [CrossRef] [PubMed]
  91. Yuan, H.; Cho, H.; Chen, H.H.; Panagia, M.; Sosnovik, D.E.; Josephson, L. Fluorescent and radiolabeled triphenylphosphonium probes for imaging mitochondria. Chem. Commun. 2013, 49, 10361–10363. [Google Scholar] [CrossRef] [PubMed]
  92. Nigam, S.; Burke, B.P.; Davies, L.H.; Domarkas, J.; Wallis, J.F.; Waddell, P.G.; Waby, J.S.; Benoit, D.M.; Seymour, A.-M.; Cawthorne, C.; et al. Structurally optimized BODIPY derivatives for imaging of mitochondrial dysfunction in cancer and heart cells. Chem. Commun. 2016, 52, 7114–7117. [Google Scholar] [CrossRef]
  93. Walter, E.R.H.; Lee, L.C.-C.; Leung, P.K.-K.; Lo, K.K.-W.; Long, N.J. Mitochondria-targeting biocompatible fluorescent BODIPY probes. Chem. Sci. 2024, 15, 4846–4852. [Google Scholar] [CrossRef] [PubMed]
  94. Das, R.S.; Saha, P.C.; Sepay, N.; Mukherjee, A.; Chatterjee, S.; Guha, S. Design and synthesis of near-infrared mechanically interlocked molecules for specific targeting of mitochondria. Org. Lett. 2020, 22, 5839–5843. [Google Scholar] [CrossRef] [PubMed]
  95. Kommidi, S.S.R.; Atkinson, K.M.; Smith, B.D. Steric protection of near-infrared fluorescent dyes for enhanced bioimaging. J. Mater. Chem. B 2024, 12, 8310–8320. [Google Scholar] [CrossRef] [PubMed]
  96. Li, D.-H.; Smith, B.D. Molecular recognition using tetralactam macrocycles with parallel aromatic sidewalls. Beilstein J. Org. Chem. 2019, 15, 1086–1095. [Google Scholar] [CrossRef]
  97. Gassensmith, J.J.; Baumes, J.M.; Smith, B.D. Discovery and early development of squaraine rotaxanes. Chem. Commun. 2009, 6329–6338. [Google Scholar] [CrossRef]
  98. Das, R.S.; Maiti, D.; Kar, S.; Bera, T.; Mucherjee, A.; Saha, R.C.; Mondal, A.; Guha, S. Design of water-soluble rotaxane-capped superparamagnetic, ultrasmall Fe3O4 nanoparticles for targeted NIR fluorescence imaging in combination with magnetic resonance imaging. J. Am. Chem. Soc. 2023, 145, 20451–20461. [Google Scholar] [CrossRef]
  99. Liu, J.; Zhao, B.; Zhang, X.; Guan, D.; Sun, K.; Zhang, Y.; Liu, Q. Thiolation for enhancing photostability of fluorophores at the single-molecule level. Angew. Chem. Int. Ed. 2024, 63, e202316192. [Google Scholar] [CrossRef]
  100. Jacob, M.; Schmitt, A.; Jung, G. Disabling photoinduced electron transfer in 4,4-difluoro-8(-4’-hydroxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene by phosphorylation. J. Fluoresc. 2008, 18, 639–644. [Google Scholar] [CrossRef] [PubMed]
  101. Chen, L.; Wu, D.; Yoon, J. Recent advances in the development of chromophore-based chemosensors for nerve agents and phosgene. ACS Sens. 2018, 3, 27–43. [Google Scholar] [CrossRef] [PubMed]
  102. Meng, W.-Q.; Sedgwick, A.C.; Kwon, N.; Sun, M.; Xiao, K.; He, X.-P.; Anslyn, E.V.; James, T.D.; Yoon, J. Fluorescent probes for the detection of chemical warfare agents. Chem. Soc. Rev. 2023, 52, 601–662. [Google Scholar] [CrossRef]
  103. Kim, T.I.; Maity, S.B.; Bouffard, J.; Kim, Y. Molecular rotors for the detection of chemical warfare agent simulants. Anal. Chem. 2016, 88, 9259–9263. [Google Scholar] [CrossRef] [PubMed]
  104. Lu, Z.; Fan, W.; Shi, X.; Black, C.A.; Fan, C.; Wang, F. A highly specific BODIPY-based fluorescent probe for the detection of nerve-agent simulants. Sens. Actuators B 2018, 255, 176–182. [Google Scholar] [CrossRef]
  105. Paez-Perez, M.; Kuimova, M.K. Molecular rotors: Fluorescent sensors for microviscosity and conformation of biomolecules. Angew. Chem. Int. Ed. 2024, 63, e202311233. [Google Scholar] [CrossRef]
  106. Lee, S.C.; Heo, J.; Woo, C.; Lee, J.-A.; Seo, Y.H.; Lee, C.-L.; Kim, S.; Kwon, O.-P. Fluorescent molecular rotors for viscosity sensors. Chem. Eur. J. 2018, 24, 13706–13718. [Google Scholar] [CrossRef] [PubMed]
  107. Jang, Y.J.; Tsay, O.G.; Murale, D.P.; Jeong, J.A.; Segev, A.; Churchill, D.G. Novel and selective detection of Tabun mimics. Chem. Commun. 2014, 50, 7531–7534. [Google Scholar] [CrossRef] [PubMed]
  108. Li, S.-S.; Zheng, Y.-C.; Zhu, X.-M.; Wang, H.-B.; Liang, L.-H.; Wang, X.-Z.; Yuan, L.; Zhang, F.-H.; Zheng, H.; Zhao, C.-L. A novel BODIPY-based fluorescent probe for sensitive and selective detection of nerve agent simulants through base-assisted photo-induced electron transfer process. Sens. Actuators B 2021, 337, 129804. [Google Scholar] [CrossRef]
  109. Begera, K.C.; Mahanty, R.; Ravikanth, M. 3-Pyrrolyl BODIPY based Schiff base fluorophores: A selective chemodosimetric and optical sensor for diethyl chlorophosphate. ChemPlusChem 2023, 88, e202300132. [Google Scholar]
  110. Dagnaw, F.W.; Cai, Y.-P.; Song, Q.-H. Rapid and sensitive detection of nerve agent mimics by meso-substituted BODIPY piperazines as fluorescent chemosensors. Dyes Pigment. 2021, 189, 109257. [Google Scholar] [CrossRef]
  111. Anitha, T.; Mrinalini, M.; Vani, D.; Prasanthkumar, S.; Reddy, K.R.; Giribabu, L. Synthesis and opto-electronic properties of BODIPY o-OPhos systems. Photochem. Photobiol. 2020, 96, 1182–1190. [Google Scholar] [CrossRef] [PubMed]
  112. Zhang, S.; Zhou, C.; Zhang, M.; Zhao, Y.; Yuan, B.; Yang, B.; Li, H. Solvent-driven micro/nanostructures of squaraine and croconane dyes based on quinoxalinone for visual detection of nerve agent simulants. Dyes Pigments 2022, 208, 110824. [Google Scholar] [CrossRef]
  113. Pyuol, M.; Encinas, C.; Rivera, L.; Miltsov, S.; Alonso, J. Characterization of new norcyanine dyes and their application as pH chromoionophores in optical sensors. Dyes Pigments 2007, 73, 383–389. [Google Scholar] [CrossRef]
  114. Zhao, J.; Qin, M.; You, J.; Liu, K.; Ding, L.; Liu, T.; Kong, J.; Fang, Y. Rapid and colorimetric evaluation of G-series nerve agents and simulants using the squaraine-ethanolamine adducts. Dyes Pigments 2022, 197, 109870. [Google Scholar] [CrossRef]
  115. Simon, P.; Tichotova, M.; Garcia Gallardo, M.; Prochazkova, E.; Baszcynzki, O. Phosphate-based self-immolative linkers for tunable double cargo release. Chem. Eur. J. 2021, 27, 12763–12775. [Google Scholar] [CrossRef] [PubMed]
  116. Djud, M.; Tichotova, M.; Prochazkova, E.; Baszczynski, O. Phosphate-based self-immolative linkers for the delivery of amine-containing drugs. Molecules 2021, 26, 5160. [Google Scholar] [CrossRef] [PubMed]
  117. Li, H.; Wang, J.; Jiao, L.; Hoa, E. BODIPY-base photocages: Rational design and their medical application. Chem. Soc. Rev. 2024, 60, 5770–5789. [Google Scholar]
  118. Singh, P.K.; Majumdar, P.; Singh, S.P. Advances in BODIPY photocleavable protecting groups. Coord. Chem. Rev. 2021, 449, 214193. [Google Scholar] [CrossRef]
  119. Shrestha, P.; Mukhopadhya, A.; Dissanayake, K.C.; Winter, A.H. Efficiency of functional groups caging with second-generation green- and red-light labile BODIPY photoremovable protecting groups. J. Org. Chem. 2022, 87, 14334–14341. [Google Scholar] [CrossRef] [PubMed]
  120. Kaufmann, J.; Müller, P.; Andreadou, E.; Heckel, A. Green-light activatable BODIPY and coumarin 5’-caps for oligonucleotide photocaging. Chem. Eur. J. 2022, 28, e202200477. [Google Scholar] [CrossRef]
  121. Benaim, G.; Paniz-Mondolfi, A. Umasking the mechanism behind miltefosine: Revealing the disruption of intracellular Ca2+ homeostasis as a rational therapeutic target in Leishmaniasis and Chagas disease. Biomolecules 2024, 14, 406. [Google Scholar] [CrossRef] [PubMed]
  122. de Castro Spadari, C.; Borba-Santos, L.P.; Rozental, S.; Ishida, K. Miltefosine repositioning: A review of potential alternative antifungal therapy. J. Med. Mycol. 2023, 33, 101436. [Google Scholar] [CrossRef] [PubMed]
  123. Dorlo, T.P.; Balasegaram, M.; Beijnen, J.H.; de Vries, J. Miltefosine: A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J. Antimicrob. Chemother. 2012, 67, 2576–2597. [Google Scholar] [CrossRef] [PubMed]
  124. Hornillos, V.; Carrillo, E.; Amat-Guerri, F.; Acuña, A.U. Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine. Bioorg. Med. Chem. Lett. 2008, 18, 6336–6339. [Google Scholar] [CrossRef] [PubMed]
  125. Marcos, S.; Requeji-Isidro, J.; Merayo-Lloves, J.; Acuna, A.U.; Hornillos, V.; Carrilo, E.; Pérez-Merino, P.; del Olmo-Aguado, S.; del Aguila, C.; Amat-Guerri, F.; et al. Fluorescent labeling of Acanthamoeba assessed in situ from corneal sectioned microscopy. Biomed. Opt. Exp. 2012, 3, 2489–2499. [Google Scholar] [CrossRef] [PubMed]
  126. de la Torre, B.G.; Hornillos, V.; Luque-Ortega, J.R.; Abengózar, M.A.; Amat-Guerri, F.; Acuna, A.U.; Rivas, L.; Andreu, B. A BODIPY-embedding miltefosine analog linked to cell penetrating Tat(48-60) peptide factors intracellular delivery and visualization of the antiparasitic drug. Amino Acids 2014, 46, 1047–1058. [Google Scholar] [CrossRef] [PubMed]
  127. Courrier, E.; Maret, C.; Charaoui-Boukerzaza, S.; Lambert, V.; De Nicola, A.; Muzuzu, W.; Ulrich, G.; Rabrin, H.; Flori, P.; Moine, B.; et al. Synthesis of fluorescent BODIPY-labeled analogue of staining of Acathamoeba. ChemistrySelect 2018, 3, 7674–7679. [Google Scholar] [CrossRef]
  128. Dehmchi, D.A.; Bouchareb, F.; Berredjem, M. Recent advances in the synthesis of phosphoramidate derivatives: A comprehensive review and analysis. Synth. Commun. 2024, 54, 1909–1939. [Google Scholar] [CrossRef]
  129. Itumoh, E.J.; Data, S.; Leitao, E.M. Opening up the toolbox: Synthesis and mechanisms of phosphoramidates. Molecules 2020, 25, 3684. [Google Scholar] [CrossRef] [PubMed]
  130. Oliveira, F.M.; Barbosa, L.C.A.; Ismail, F.M.D. The diverse pharmacology and medicinal chemistry of phosphoramidates–A review. RSC Adv. 2014, 4, 18998–19012. [Google Scholar] [CrossRef]
  131. Machado, L.A.; de Souza, M.C.; da Silva, C.M.; Yineda, J.; de Rezende, L.C.D.; Emery, F.S.; de Simobe, C.A.; da Silva Júnior, E.N.; Pedrosa, L.F. On the synthesis, optical and computational studies of novel BODIPY-based phosphoramidate fluorescent dyes. J. Fluor. Chem. 2019, 220, 9–15. [Google Scholar] [CrossRef]
  132. da Silva Marques, B.; Nascimento de Andrade, K.; Pereira Peixoto, B.; dos Santos, F.M., Jr.; Ferreira Pedrosa, L.; Costa de Souza, M. Sequential nucleophilic aromatic substitutions on cyanuric chloride: Synthesis of BODIPY derivatives and mechanistic insights. Org. Biomol. Chem. 2024, 22, 5987–5998. [Google Scholar] [CrossRef]
  133. Teeuwen, P.C.; Melissari, Z.; Senge, M.O.; Williams, R.M. Metal coordination effects on the photophysics of dipyrrinato photosensitizers. Molecules 2022, 27, 6967. [Google Scholar] [CrossRef]
  134. Baudron, S.A. Dipyrrin based metal complexes: Reactivity and catalysis. Dalton Trans. 2020, 49, 6161–6175. [Google Scholar] [CrossRef]
  135. Jiang, X.-D.; Zhao, J.; Xi, D.; Yu, H.; Guan, J.; Li, S.; Sun, C.-L.; Xiao, L.-J. A new water-soluble phosphorus-dipyrromethene and phosphorus-azadipyrromethene dye: PODIPY/aza-PODIPY. Chem. Eur. J. 2015, 21, 6079–6082. [Google Scholar] [CrossRef]
  136. Jiang, X.-D.; Yu, H.-F.; Zhao, J.-J.; Sun, C.-L.; Xiao, L.-J. A colorimetric chemosensor based on new water-soluble BODIPY dye for Hg2+ detection. Chin. Chem. Lett. 2015, 26, 1241–1245. [Google Scholar] [CrossRef]
  137. Marfin, Y.S.; Vodyanova, O.S.; Usoltsev, S.D.; Kazak, A.V.; Rumyantsev, E.V. Oxophosphoryl complexes of dipyrrin: Spectral and aggregation characteristics of solutions and thin films. Crystallogr. Rep. 2019, 64, 644–648. [Google Scholar] [CrossRef]
  138. Fihey, A.; Favennec, A.; Le Guennic, B.; Jacquemin, D. Investigating the properties of PODIPYs (phosphorus-dipyrromethene) with ab initio tools. Phys. Chem. Chem. Phys. 2016, 18, 9358–9366. [Google Scholar] [CrossRef]
  139. Wang, L.; Yang, Y.-X.; Shi, X.; Mignani, S.; Caminade, A.-M.; Majoral, J.-P. Cyclotripohosphazene core-based dendrimers for biomedical applications: An update on recent advances. J. Mater. Chem. B 2018, 6, 884–895. [Google Scholar] [CrossRef]
  140. Usri, S.N.K.; Jamain, Z.; Makmud, M.Z.H. A review of synthesis, structural, flame retardancy and dielectric properties of hexasubstituted cyclotriphosphazene. Polymers 2021, 13, 2916. [Google Scholar] [CrossRef] [PubMed]
  141. Wang, L.; Su, X.; Xire, J.-H.; Ming, L.-J. Specific recognitions of multivalent cyclotriphosphazene derivatives in sensing, imaging, theranostics, and biomimetic catalysis. Coord. Chem. Rev. 2022, 454, 214326. [Google Scholar] [CrossRef]
  142. Liu, P.; Wang, L.; Yang, Y.; Qu, Y.; Ming, L.-J. Recent advances of cyclotriphosphazene derivatives as fluorescent dyes. Dyes Pigment. 2021, 188, 109214. [Google Scholar] [CrossRef]
  143. Caminade, A.-M.; Hameau, A.; Moineau-Chane Ching, K.; Turrin, C.-O. Fluorescent groups at the core of phosphorus dentrons and their properties. Helv. Chim. Acta. 2023, 106, e202300048. [Google Scholar] [CrossRef]
  144. Rao, M.R.; Bolligaria, R.; Butcher, R.J.; Ravikanth, M. Hexa boron-dipyrromethene cyclotriphosphazenes: Synthesis, crystal structure, and photophysical properties. Inorg. Chem. 2010, 49, 10606–10616. [Google Scholar] [CrossRef] [PubMed]
  145. Eserci, H.; Öztürk, E.; Okutan, E. Novel BODIPY-bridged cyclotriphosphazenes. Turk. J. Chem. 2020, 44, 74–86. [Google Scholar] [CrossRef] [PubMed]
  146. Çosut, B. Highly efficient energy transfer in BODIPY-pyrene decorated cyclotriphosphazene. Dyes Pigment. 2014, 100, 11–16. [Google Scholar] [CrossRef]
  147. Senkuyutu, E.; Cebesoy, Z.; Yenilmez Çiftçi, G.; Tanrıverdi Eçik, E. Study on the synthesis, photophysical properties and singlet oxygen generation behavior of BODIPY-functionalized cyclotriphosphazenes. J. Fluoresc. 2017, 27, 595–601. [Google Scholar] [CrossRef]
  148. Çetindere, S.; Okutan, E.; Oguz Tümay, S.; Yesilot, S.; Kiliç, A. Novel water-soluble cyclotriphosphazene-bodipy conjugates: Synthesis, characterization and photophysical properties. J. Fluoresc. 2019, 29, 1143. [Google Scholar] [CrossRef] [PubMed]
  149. Tanrıverdi Eçik, E.; Senkuytu, E.; Cebesoy, Z.; Ynilmez Çiftçi, G. BODIPY decorated dendrimeric cyclotriphosphazene photosensitizers: Synthesis and efficient singlet oxygen generators. RSC Adv. 2016, 6, 47600–47606. [Google Scholar] [CrossRef]
  150. Yıldız Gül, E.; Tanrıverdi Eçik, E. Cyclophosphazene-based photocatalysts containing orthogonal BODIPY moieties for chemical transformations. ChemPhotoChem 2024, 8, e202300314. [Google Scholar]
  151. Cetindere, S.; Yesilot, S.; Kiliç, A. Pyrene-BODIPY-substituted novel water-soluble cyclotriphosphazenes: Synthesis, characterization, and photophysical properties. Turk. J. Chem. 2020, 44, 1–14. [Google Scholar] [CrossRef]
  152. Senkuytu, E.; Öztürk, E.; Aydinogly, F.; Tanrıverdi Eçik, E.; Okutan, E. Cyclotriphosphazene cored naphthalimide-BODIPY dendrimeric systems: Synthesis, photophysical and antimicrobial properties. Inorg. Chim. Acta 2020, 502, 119386. [Google Scholar] [CrossRef]
  153. Sarikaya, S.Y.; Yesilot, S.; Kiliç, A.; Okutan, E. Visible light harvesting BODIPY-cyclotriphosphazene-fullerene assemblies: Photophysical properties and solvent effect on photosensitized generation of singlet oxygen. Dyes Pigments 2019, 162, 734–740. [Google Scholar] [CrossRef]
  154. Çetindere, S.; Oguz Tümay, S.; Kiliç, A.; Durmus, M.; Yesilot, S. Synthesis and physico-chemical properties of cyclotriphosphazene-BODIPY conjugates. Dyes Pigments 2017, 139, 517–523. [Google Scholar] [CrossRef]
  155. Kwon, N.; Kim, K.H.; Park, S.; Cho, Y.; Park, E.-Y.; Lim, J.; Çetindere, S.; Oguz Tümay, S.; Kim, W.J.; Li, X.; et al. Hexa-BODIPY-cyclotriphosphazene based nanoparticle for NIR fluorescence/photoacoustic dual-modal imaging and photothermal cancer therapy. Biosens. Bioelectron. 2022, 216, 114612. [Google Scholar] [CrossRef] [PubMed]
  156. Yıldız Gül, E.; Aydın Karataş, E.; Aydın Doğan, H.; Yenilmez Çiftçi, G.; Tanrıverdi Eçik, E. BODIPY precursors and their cyclotriphosphazene derivatives: Synthesis, photochemical properties and their application in PDT. Spectrochim. Acta. A 2024, 311, 124006. [Google Scholar] [CrossRef]
  157. Senkuytu, E.; Tanrıverdi Eçik, E. Octa-BODIPY derivative dendrimeric cyclotetraphosphazenes: Photophysical properties and fluorescent chemosensor for Co2+ ions. Spectrochim. Acta A 2017, 173, 863–870. [Google Scholar] [CrossRef] [PubMed]
  158. Tanrıverdi Eçik, E.; Senkuyutu, E.; Okutan, E.; Çiftçi, G.Y. Synthesis of BODIPY-cyclotetraphosphazene triad systems and their sensing behaviors towards Co(II) and Cu(II). Inorg. Chim. Acta 2019, 495, 119009. [Google Scholar] [CrossRef]
  159. Senkuytu, E.; Eçik, E.T. Novel fully-BODIPY functionalized cyclotetraphosphazene photosensitizers having high singlet oxygen quantum yields. Spectrochim. Acta A 2017, 182, 26–31. [Google Scholar] [CrossRef]
  160. Zhao, Z.; Zhang, H.; Lam, J.W.Y.; Tang, B.Z. Aggregation-induced emission: New vistas at the aggregate level. Angew. Chem. Int. Ed. 2020, 59, 9888–9907. [Google Scholar] [CrossRef]
  161. Peng, Q.; Shuai, Z. Molecular mechanism of aggregation-induced emission. Aggregate 2021, 2, e91. [Google Scholar] [CrossRef]
  162. Antunes, P.; Cruz, A.; Barbosa, J.; Bonifácio, V.D.B.; Pinto, S.N. Lipid droplets in cancer: From composition and role to imaging and therapeutics. Molecules 2022, 27, 991. [Google Scholar] [CrossRef] [PubMed]
  163. Wang, S.; Wang, Q.; Lv, Y.; Liu, Z.; Lee, K.; Kim, D.; Won, M.; Shen, J.; Kim, J.S. Fluorescence imaging-guided lipid droplets-localized photodynamic therapy. Aggregate 2024, e665. [Google Scholar] [CrossRef]
Figure 1. General structures of BODIPY (with the numbering system) and squaraine dyes. R = substituent, functional group.
Figure 1. General structures of BODIPY (with the numbering system) and squaraine dyes. R = substituent, functional group.
Molecules 30 00116 g001
Scheme 1. General syntheses of BODIPY dyes. R1, R2, R3, R4 = substituent, functional group; [O] = oxidizing agent.
Scheme 1. General syntheses of BODIPY dyes. R1, R2, R3, R4 = substituent, functional group; [O] = oxidizing agent.
Molecules 30 00116 sch001
Scheme 2. General syntheses of squaraine dyes. R, R1, R2 = substituent, functional group.
Scheme 2. General syntheses of squaraine dyes. R, R1, R2 = substituent, functional group.
Molecules 30 00116 sch002
Scheme 3. Synthesis of water-soluble, phosphonate-containing BODIPY dyes.
Scheme 3. Synthesis of water-soluble, phosphonate-containing BODIPY dyes.
Molecules 30 00116 sch003
Scheme 4. Synthesis of water-soluble BODIPY dyes via incorporation of phosphonate group at the meso-substituent. TSTU: O-(N-Suc-cinimidyl)-1,1,3,3-teramethyl-uronium tetrafluoroborate, NMP: N-methyl-2-pyrrolidone, PyBrOP: (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate.
Scheme 4. Synthesis of water-soluble BODIPY dyes via incorporation of phosphonate group at the meso-substituent. TSTU: O-(N-Suc-cinimidyl)-1,1,3,3-teramethyl-uronium tetrafluoroborate, NMP: N-methyl-2-pyrrolidone, PyBrOP: (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate.
Molecules 30 00116 sch004
Scheme 5. Synthesis of phosphonate-containing BODIPYs via functionalization of 3-/5-methyl substituents. NBS: N-bromosuccinimide.
Scheme 5. Synthesis of phosphonate-containing BODIPYs via functionalization of 3-/5-methyl substituents. NBS: N-bromosuccinimide.
Molecules 30 00116 sch005
Scheme 6. Direct phosphorylation of BODIPY scaffold.
Scheme 6. Direct phosphorylation of BODIPY scaffold.
Molecules 30 00116 sch006
Scheme 7. Synthesis of BODIPY 12 using phopshonate-containing aldehyde. TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone.
Scheme 7. Synthesis of BODIPY 12 using phopshonate-containing aldehyde. TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone.
Molecules 30 00116 sch007
Figure 2. Structures of phosphonate-containing BODIPY dyes utilized in computational studies.
Figure 2. Structures of phosphonate-containing BODIPY dyes utilized in computational studies.
Molecules 30 00116 g002
Scheme 8. Synthesis of water-soluble, phosphonate-containing squaraine dye 17.
Scheme 8. Synthesis of water-soluble, phosphonate-containing squaraine dye 17.
Molecules 30 00116 sch008
Scheme 9. Synthesis of air-stable primary phosphine-containing BODIPYs 18 and 19.
Scheme 9. Synthesis of air-stable primary phosphine-containing BODIPYs 18 and 19.
Molecules 30 00116 sch009
Scheme 10. Zirconium-catalyzed hydrophosphination and dimerization of 18.
Scheme 10. Zirconium-catalyzed hydrophosphination and dimerization of 18.
Molecules 30 00116 sch010
Figure 3. Structures of Zr-, Mo-, and W-containing BODIPY dyes.
Figure 3. Structures of Zr-, Mo-, and W-containing BODIPY dyes.
Molecules 30 00116 g003
Scheme 11. Synthesis of tertiary phosphine-containing BODIPY dyes 2528 and their respective complexes with coinage metals; the isolated yields of the complexes are given in parentheses. COD: cyclooctadiene, hfa: hexafluoroacetylacetonato, tht: tetrahydrothiophene.
Scheme 11. Synthesis of tertiary phosphine-containing BODIPY dyes 2528 and their respective complexes with coinage metals; the isolated yields of the complexes are given in parentheses. COD: cyclooctadiene, hfa: hexafluoroacetylacetonato, tht: tetrahydrothiophene.
Molecules 30 00116 sch011
Scheme 12. Synthesis of phosphino-amine/thioether-containing BODIPY dyes 2931 and their Pt-complexes. Green glow indicates high-emissive (Φf > 0.10) dyes; grey glow indicates low-emissive (Φf < 0.07) dyes; the extent of glow is directly proportional to Φf. TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, COD: cyclooctadiene.
Scheme 12. Synthesis of phosphino-amine/thioether-containing BODIPY dyes 2931 and their Pt-complexes. Green glow indicates high-emissive (Φf > 0.10) dyes; grey glow indicates low-emissive (Φf < 0.07) dyes; the extent of glow is directly proportional to Φf. TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, COD: cyclooctadiene.
Molecules 30 00116 sch012
Scheme 13. Synthesis of dye 38 and its respective metal complexes. NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Scheme 13. Synthesis of dye 38 and its respective metal complexes. NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Molecules 30 00116 sch013
Scheme 14. Synthesis of 39-Ru and 40-Ru BODIPY dyes and the structure of non-fluorescent Ru-drug candidate 41.
Scheme 14. Synthesis of 39-Ru and 40-Ru BODIPY dyes and the structure of non-fluorescent Ru-drug candidate 41.
Molecules 30 00116 sch014
Scheme 15. Synthesis of multifunctional Au-containing BODIPY scaffolds.
Scheme 15. Synthesis of multifunctional Au-containing BODIPY scaffolds.
Molecules 30 00116 sch015
Scheme 16. Synthesis of re-containing isomeric dyes 51 and 52 (cis/mer and cis/fac isomers) and 53. The yield of 51 in toluene synthesis was not provided; the isolated yields for 52 isomers are given in parentheses.
Scheme 16. Synthesis of re-containing isomeric dyes 51 and 52 (cis/mer and cis/fac isomers) and 53. The yield of 51 in toluene synthesis was not provided; the isolated yields for 52 isomers are given in parentheses.
Molecules 30 00116 sch016
Scheme 17. Synthesis of 99mTc-containing BODIPY dye 54.
Scheme 17. Synthesis of 99mTc-containing BODIPY dye 54.
Molecules 30 00116 sch017
Scheme 18. Synthesis of BODIPY dyes 55 and 56.
Scheme 18. Synthesis of BODIPY dyes 55 and 56.
Molecules 30 00116 sch018
Figure 4. Structures of dyes 57, 58, and the Hammett plot relating electronic effects of the meso-substituents and λabsmax. Colors of the symbols in the graph correlate with the color of the meso-substituent in the structures.
Figure 4. Structures of dyes 57, 58, and the Hammett plot relating electronic effects of the meso-substituents and λabsmax. Colors of the symbols in the graph correlate with the color of the meso-substituent in the structures.
Molecules 30 00116 g004
Scheme 19. Synthesis of dyes 58, 59, and 60 and their respective metal complexes. 61 was obtained as a side product from reactions involving 59 as the starting material.
Scheme 19. Synthesis of dyes 58, 59, and 60 and their respective metal complexes. 61 was obtained as a side product from reactions involving 59 as the starting material.
Molecules 30 00116 sch019
Scheme 20. Synthesis of the OFF-ON probe 62 (OFF-state) and its oxidation to 63 (ON-state).
Scheme 20. Synthesis of the OFF-ON probe 62 (OFF-state) and its oxidation to 63 (ON-state).
Molecules 30 00116 sch020
Scheme 21. Synthesis of OFF-ON probes 57 (OFF-state) and 65 (OFF-state) and their oxidation to 64 (ON-state) and 66 (OFF-state).
Scheme 21. Synthesis of OFF-ON probes 57 (OFF-state) and 65 (OFF-state) and their oxidation to 64 (ON-state) and 66 (OFF-state).
Molecules 30 00116 sch021
Scheme 22. Nucleophilic phosphine addition to squaraine 66, making metal sensor 67. L = nBu, NMe2, p-MeOHC6H4; X: metal ion. See text for details.
Scheme 22. Nucleophilic phosphine addition to squaraine 66, making metal sensor 67. L = nBu, NMe2, p-MeOHC6H4; X: metal ion. See text for details.
Molecules 30 00116 sch022
Scheme 23. Reaction of squaraine dyes 69 and 70 with the phosphine producing 71 and 72. Dearomative mechanism (left), based on B3LYP+D3/6-311+G**+CPCM calculation, is shown for conversion of 69 to 71. X = H, metal. See text for details.
Scheme 23. Reaction of squaraine dyes 69 and 70 with the phosphine producing 71 and 72. Dearomative mechanism (left), based on B3LYP+D3/6-311+G**+CPCM calculation, is shown for conversion of 69 to 71. X = H, metal. See text for details.
Molecules 30 00116 sch023
Figure 5. Structures of selected Ph3P+-containing BODIPY dyes used in mitochondria imaging; citation is given in brackets next to the compound number: 73 [70], 74 [71], 75 [72], 76 [73], 77 [74], 78 [75], 79 [76], 80 [77], 81 [78], 82 [79], 83 [80], 84 [81], 85 [82], 86 [83], 87 [84], 88 [85], 89 [86], 90 [87], 91 [88].
Figure 5. Structures of selected Ph3P+-containing BODIPY dyes used in mitochondria imaging; citation is given in brackets next to the compound number: 73 [70], 74 [71], 75 [72], 76 [73], 77 [74], 78 [75], 79 [76], 80 [77], 81 [78], 82 [79], 83 [80], 84 [81], 85 [82], 86 [83], 87 [84], 88 [85], 89 [86], 90 [87], 91 [88].
Molecules 30 00116 g005
Scheme 24. Synthesis of dyes 92-H and 92-Et. See text for the NP preparation using these dyes. DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Scheme 24. Synthesis of dyes 92-H and 92-Et. See text for the NP preparation using these dyes. DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Molecules 30 00116 sch024
Scheme 25. Synthesis of 18F-labeld Ph3P+-containing dye 93. TEAHC: tetraethylammonium hydrogen carbonate.
Scheme 25. Synthesis of 18F-labeld Ph3P+-containing dye 93. TEAHC: tetraethylammonium hydrogen carbonate.
Molecules 30 00116 sch025
Scheme 26. Synthesis of phosphonium-containing dyes 94 and 95.
Scheme 26. Synthesis of phosphonium-containing dyes 94 and 95.
Molecules 30 00116 sch026
Scheme 27. Modular synthetic approach to phosphonium-containing BODIPY imaging probes 97102. Isolated yields are given in parentheses. TFA: trifluoroacetic acid.
Scheme 27. Modular synthetic approach to phosphonium-containing BODIPY imaging probes 97102. Isolated yields are given in parentheses. TFA: trifluoroacetic acid.
Molecules 30 00116 sch027
Scheme 28. Synthesis of Ph3P+-containing squaraine 103. MW: microwave heating, HATU: 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazole[4,5-b]pyridinium 3-oxid hexafluorophosphate.
Scheme 28. Synthesis of Ph3P+-containing squaraine 103. MW: microwave heating, HATU: 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazole[4,5-b]pyridinium 3-oxid hexafluorophosphate.
Molecules 30 00116 sch028
Scheme 29. Synthesis of Ph3P+-containing rotaxane encapsulated squaraine 104. HATU: 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazole[4,5-b]pyridinium 3-oxid hexafluorophosphate.
Scheme 29. Synthesis of Ph3P+-containing rotaxane encapsulated squaraine 104. HATU: 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazole[4,5-b]pyridinium 3-oxid hexafluorophosphate.
Molecules 30 00116 sch029
Figure 6. Structure of 105 used for the preparation of multimodal nanoparticles.
Figure 6. Structure of 105 used for the preparation of multimodal nanoparticles.
Molecules 30 00116 g006
Scheme 30. Synthesis of Ph3P+-containing thiosquaraine 106. NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Scheme 30. Synthesis of Ph3P+-containing thiosquaraine 106. NHS: N-hydroxysuccinimide, EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Molecules 30 00116 sch030
Scheme 31. Attempted syntheses of BODIPY 107.
Scheme 31. Attempted syntheses of BODIPY 107.
Molecules 30 00116 sch031
Figure 7. Structures of selected organophosphorus nerve agents and respective simulants.
Figure 7. Structures of selected organophosphorus nerve agents and respective simulants.
Molecules 30 00116 g007
Scheme 32. Phosphorylation of HO-containing BODIPY dyes.
Scheme 32. Phosphorylation of HO-containing BODIPY dyes.
Molecules 30 00116 sch032
Scheme 33. Oxime-containing BODIPY dyes as sensors of DCP and DCNP. (A): [107]; (B): [108]; (C): [109].
Scheme 33. Oxime-containing BODIPY dyes as sensors of DCP and DCNP. (A): [107]; (B): [108]; (C): [109].
Molecules 30 00116 sch033
Scheme 34. Piperazine-containing BODIPY dyes and their products upon reaction with DCP.
Scheme 34. Piperazine-containing BODIPY dyes and their products upon reaction with DCP.
Molecules 30 00116 sch034
Scheme 35. A modular approach to phosphorylated BODIPY dyes with restricted rotations. TBHP: t-butyl hydroperoxide, TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone.
Scheme 35. A modular approach to phosphorylated BODIPY dyes with restricted rotations. TBHP: t-butyl hydroperoxide, TFA: trifluoroacetic acid, DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone.
Molecules 30 00116 sch035
Scheme 36. Synthesis of 132 (first step); solvent-controlled equilibrium (second step); tentatively proposed DCP-sensing mechanism by 132–basic (third step).
Scheme 36. Synthesis of 132 (first step); solvent-controlled equilibrium (second step); tentatively proposed DCP-sensing mechanism by 132–basic (third step).
Molecules 30 00116 sch036
Scheme 37. Structures of squaraine dyes 134 and 135 and the tentative sensing mechanism of DCP. Blue and yellow glowing indicates emissive and non-emissive species, respectively.
Scheme 37. Structures of squaraine dyes 134 and 135 and the tentative sensing mechanism of DCP. Blue and yellow glowing indicates emissive and non-emissive species, respectively.
Molecules 30 00116 sch037
Scheme 38. Synthesis of BODIPY photocages 136 and 137.
Scheme 38. Synthesis of BODIPY photocages 136 and 137.
Molecules 30 00116 sch038
Scheme 39. Synthesis of BODIPY-containing oligonucleotide 139.
Scheme 39. Synthesis of BODIPY-containing oligonucleotide 139.
Molecules 30 00116 sch039
Figure 8. Structure of miltefosine.
Figure 8. Structure of miltefosine.
Molecules 30 00116 g008
Scheme 40. Synthesis of fluorescent miltefosine analogues 140 and 141.
Scheme 40. Synthesis of fluorescent miltefosine analogues 140 and 141.
Molecules 30 00116 sch040
Figure 9. Structure of the sulfide-containing BODIPY dye 142 used for the synthesis of compounds 143 and 144.
Figure 9. Structure of the sulfide-containing BODIPY dye 142 used for the synthesis of compounds 143 and 144.
Molecules 30 00116 g009
Scheme 41. Synthesis of BODIPY 145.
Scheme 41. Synthesis of BODIPY 145.
Molecules 30 00116 sch041
Scheme 42. Synthesis of phosphoramidate-containing BODIPY dyes 146. MW: microwave heating.
Scheme 42. Synthesis of phosphoramidate-containing BODIPY dyes 146. MW: microwave heating.
Molecules 30 00116 sch042
Scheme 43. Synthesis of phoshoramidate-containing BODIPY dyes 147. TFA: trifluoroacetic acid.
Scheme 43. Synthesis of phoshoramidate-containing BODIPY dyes 147. TFA: trifluoroacetic acid.
Molecules 30 00116 sch043
Scheme 44. Synthesis of PODIPY dyes 148 and 149. DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, TFA: trifluoroacetic acid.
Scheme 44. Synthesis of PODIPY dyes 148 and 149. DDQ: 2,3-dichloro-5,6-dicyano-p-benzoquinone, TFA: trifluoroacetic acid.
Molecules 30 00116 sch044
Figure 10. Structure of PODIPY 150.
Figure 10. Structure of PODIPY 150.
Molecules 30 00116 g010
Figure 11. Computational comparison PODIPY 151156 and the corresponding BODIPY dyes.
Figure 11. Computational comparison PODIPY 151156 and the corresponding BODIPY dyes.
Molecules 30 00116 g011
Scheme 45. Synthesis of cyclotriphosphazene-containing BODIPYs 157160.
Scheme 45. Synthesis of cyclotriphosphazene-containing BODIPYs 157160.
Molecules 30 00116 sch045
Figure 12. Structures of di-cyclotriphosphazene BODIPY 161 and pyrene-BODIPY dyes 162 and 163.
Figure 12. Structures of di-cyclotriphosphazene BODIPY 161 and pyrene-BODIPY dyes 162 and 163.
Molecules 30 00116 g012
Figure 13. Structures of BODIPY-containing cyclotriphosphazene-based dyes 164172; citation is given in brackets next to the compound number: 164 [147], 165 [148], 166 [ 148], 167 [149], 168 [150], 169 [151], 170 [151], 171 [152], 172 [152].
Figure 13. Structures of BODIPY-containing cyclotriphosphazene-based dyes 164172; citation is given in brackets next to the compound number: 164 [147], 165 [148], 166 [ 148], 167 [149], 168 [150], 169 [151], 170 [151], 171 [152], 172 [152].
Molecules 30 00116 g013
Figure 14. Structures of fullerene-containing BODIPYs 173 and 174 on a cyclotriphosphazene scaffold.
Figure 14. Structures of fullerene-containing BODIPYs 173 and 174 on a cyclotriphosphazene scaffold.
Molecules 30 00116 g014
Figure 15. Structure of 175 used as a theranostic agent.
Figure 15. Structure of 175 used as a theranostic agent.
Molecules 30 00116 g015
Scheme 46. Synthesis of spermine-modified cyclotriphosphazene BODIPYs 176 and 177.
Scheme 46. Synthesis of spermine-modified cyclotriphosphazene BODIPYs 176 and 177.
Molecules 30 00116 sch046
Figure 16. Structures of cyclotetraphosphazene-containing BODIPY dyes 178184.
Figure 16. Structures of cyclotetraphosphazene-containing BODIPY dyes 178184.
Molecules 30 00116 g016
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Favret, J.M.; Dzyuba, S.V. Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores. Molecules 2025, 30, 116. https://doi.org/10.3390/molecules30010116

AMA Style

Favret JM, Dzyuba SV. Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores. Molecules. 2025; 30(1):116. https://doi.org/10.3390/molecules30010116

Chicago/Turabian Style

Favret, Jeanne M., and Sergei V. Dzyuba. 2025. "Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores" Molecules 30, no. 1: 116. https://doi.org/10.3390/molecules30010116

APA Style

Favret, J. M., & Dzyuba, S. V. (2025). Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores. Molecules, 30(1), 116. https://doi.org/10.3390/molecules30010116

Article Metrics

Back to TopTop